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SUMMARY
Many methods have been devised for measuring vitamin B12 ab¬
sorption since the report of Heinle et al. (.1952) using the faecal
excretion method. However, though all of the currently accepted rou¬
tine tests give good results in clinical practice, all are subject to
a variety of inaccuracies, many of which cannot even be calculated.
Furthermore, none is wholly suitable for research purposes, as all
but the faecal excretion test are at best semiquantitative and the.
faecal excretion test itself is indirect, being subject to errors re¬
sulting from incomplete faecal collection.
Since the report of Reizenstein et al. (1961) on the use of
whole body counting for measuring vitamin B12 absorption, this method
has been increasingly used, at least for research purposes. The cur¬
rently available machines are sensitive, quantitative measurements of
absorption can be made directly, and the possible extent of the meth¬
odological sources of error can be measured. The purposes of the.
present work were to develop a whole body counting method for measur¬
ing vitamin B12 absorption, to assess the extent of the sources of
error, to investigate the ranges of normal and abnormal absorption as
well as the reproducibility of the results, to test the effects of
food on these, and to relate vitamin B12 absorption to intrinsic
factor secretory capacity where this was diminished.
Preliminary experiments were done to determine the best way
of testing intrinsic factor secretory capacity. Investigations in
15 subjects showed that pentagastrin gave rise to fewer unpleasant
side-effects than histamine. As 6.Opg/kg of body weight of pentagas¬
trin gave an equivalent intrinsic factor output to that obtained with
0.04ng/kg of body weight of histamine, pentagastrin was used as the
gastric stimulant of choice. Experiments were done to determine the
best conditions for collecting gastric juice so as to ensure optimum
survival of immunoassayable intrinsic factor; it was found that the
most important point was to destroy pepsin, and that doing this by
raising the pll of the gastric juice to 10 for 30 minutes did not
damage intrinsic factor. Keeping gastric juice at room, temperature
or at 4°C also preserved intrinsic factor before pepsin had been
destroyed.
In developing the whole body counting method a scanning bed
geometry was used, as it was considered that this geometry would give
the optimum results. Machine sensitivity, as defined below, was high,
being 0.014^0 or 1.4% of the test dose of radioactive vitamin B12
used. Furthermore, a comparison of two different machines, in which
studies of the 100% value were done on 29 subjects and of vitamin B12
absorption values on 25 subjects, showed that inter-machine variability
was minimal.
57Co and 58Co were used as radioactive labels. For 58Co three
energy ranges for counting were tested—0.40-0.65 Mev, 0.65-1.00 Mev,
and 0.40-1.00 Mev—and the 0.40-1.00 Mev range was chosen as giving
the best combination of sensitivity and variation. The. coefficients
of variation for the 100% values, tested in 29 subjects, was 3.8% for
58Co (16 subjects) and 6.9% for 57Co (13 subjects), which compares
well with the results of other workers.
The excretion of radioactivity in the urine and stools during
the week of the test was investigated. Of 11 subjects, 10 lost less
than 3% of the test dose in the urine in one week, and 7 of these
lost less than 1%, Daily faecal collections in 45 subjects showed
that the mean faecal excretion of radioactivity was 0.1% of the test
dose on the seventh day of the test, and that the day of maximal ex¬
cretion of radioactivity fell before the fifth day in 93% of subjects.
It was therefore decided that the final count could be done safely on
the seventh day.
Profile scanning as a means of detecting unexcreted and unab-
sorbed radioactivity was tried in 24 subjects, 9 of whom had subnormal
levels of absorption. A collimator setting of 5cm was found most
suitable. In 21 subjects two peaks of radioactivity were seen during
the week of the test; one which did not disappear was called a "liver
peak," and one which disappeared coincidentally with excretion of
radioactivity in the faeces was called an "intestinal peak." The
"intestinal peak" could be reproduced by instilling 5-10% of the test
dose into the rectosigmoid region. As one subject with normal absorp¬
tion showed only a single peak throughout the week of the test, a one
peak pattern could not be used to exclude the presence of unabsorbed
radioactivity. However, the presence of a two peak pattern does indi¬
cate that all unabsorbed radioactivity has not been excreted.
Investigations using this method showed that when the vitamin
B12 test dose was given in the fasting state, control subjects all ab¬
sorbed 30% or more of the test dose. Five subjects with pernicious
anaemia gave test results above this value; in 4 cases only one of two
tests exceeded 30%, and in one case both tests exceeded 30%. When the
test dose was given with food, all controls absorbed 47% or more of
the test dose; one subject with pernicious anaemia exceeded this value
on one of two test occasions. Subjects with achlorhydria who did not
have pernicious anaemia very rarely gave test results below the normal
range. Failure of faecal excretion of unabsorbed radioactivity was
probably the most frequent cause of normal absorption values in perni¬
cious anaemia subjects, but the possibilities of wrong diagnosis or
occasional normal absorption of vitamin B12 in pernicious anaemia are
discussed.
The reproducibility of test results in individual subjects was
poor, especially in control and achlorhydric subjects. This was inter¬
preted as indicating that the amount of vitamin B12 absorbed on dif¬
ferent occasions in any subject can vary greatly. Reproducibility of
results improved significantly in these two groups when the test dose
was given with food; this may be the result of a combination of in¬
creased intrinsic factor secretion and slower gastric emptying when
food was given. Variations in test results could also be striking in
subjects with intestinal malabsorption or particularly partial gastrec¬
tomy; in these groups, results in both the normal and malabsorption
ranges could be obtained in the same subject.
It was noted that mean vitamin B12 absorption was greater
when the test dose was given with food in control, achlorhydric, and
especially partial gastrectomy subjects. The significance of these
results was hard to evaluate, as the same subjects were not always
given tests both with and without food. The findings are, however,
discussed in relation to similar results obtained by other workers.
A comparison was made between the results of vitamin B12 ab¬
sorption tests done by the faecal excretion and whole body counting
methods in 56 subjects. This showed that absorption results were
higher using the faecal excretion method; that this was almost cer¬
tainly due to failure of adequate collection of faeces was indicated
by the disparate results obtained in some subjects with pernicious
anaemia. It was considered that inadequate collections could have
occurred in about 23% of subjects.
In subjects who produced less than lOOOng units of intrinsic
factor in one hour after gastric stimulation, at least where absorp-
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tion tests were done in the fasting state, X analysis showed that
there was a significant relation between vitamin B12 absorption and
intrinsic factor production. However, there were also a number of in¬
dividual exceptions to this finding. Some achlorhydric subjects with¬
out pernicious anaemia absorbed vitamin B12. normally yet produced less
than lOOng units of intrinsic factor. Other subjects with pernicious
anaemia produced more than 500ng units of intrinsic factor and yet had
very poor vitamin B12 absorption. It was concluded that an absolute
differentiation between achlorhydria with and without pernicious anae¬
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Studies Included in Thesis
1
INTRODUCTION
The purpose of this introduction will be to review the
normal absorption of vitamin B12 into the body, as well as the
nature, source and daily need for this vitamin. Emphasis will be
laid on the methods which have been developed to measure the ab¬
sorption of this vitamin and in particular on work which has already
been done on the development of methods using the principle of whole
body counting. No attempt will be made to discuss the metabolism
of vitamin B12 once it has entered the body.
VITAMIN B12
Although the term vitamin B12 may be used to refer specifically
to the substance cyanocobalamin, there are many other analogues of this
material which have vitamin B12 activity biologically; these substances
may be referred to collectively as the cobalamin analogues. The vita¬
min B12 molecule consists of two major parts. One of these is the
corrin ring, which resembes a porphyrin, and when this ring contains
a cobalt atom and carries certain specific side-chain groups, it becomes
known as cobamide, as in vitamin B12. The second major part of the
molecule is a nucleotide set almost at right angles to the corrin ring.
Finally, also attached to the corrin ring through the cobalt atom,
there is a ligand. In this way there occurs a group of analogues,
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varying with respect to the ligand, some of which are shown in Table I.
Although cyanocobalamin was the first analogue to be isolated
(Rickes et al. 1948, Smith and Parker 1948), it is not the main dietary
source of vitamin B12, and it is likely that it is usually formed as a
result of the chemical decomposition of deoxyadenosylcobalamin (Toohey
and Barker 1961). Deoxyadenosylcobalamin itself is the predominant
form of vitamin B12 analogue in food, having been found in a variety
of animal livers, including that of man (Toohey and Barker 1961); how¬
ever, smaller amounts of other cobalamins may also be. found, such as
methylccbalamin, cyanocobalamin, and hydroxccobalamin (Lindstrand and
Stahlberg 1963, Rosenblum et al. 1963, Lindstrand 1964). Hydroxoco-
balamin, itself biologically inactive, may be an intermediate, and
cyanocobalamin can be converted to other forms, such as adenosylcobala-
min, in the liver and kidney (Reizenstein 1967). The cobalamins
found in food are bound to cellular protein (Cohn at al. 19ZS).
From the viewpoint of studies on vitamin B12 absorption, the
most important advance was the discovery of ways to introduce radio¬
active cobalt into the structure of the vitamin. This was first
achieved by Chaiet et al. (1950), who labelled vitamin B12 'with 60Co to
a specific activity of 0.25uc/jig, and shortly afterwards Heinle et al.
(1952) used this to measure the absorption of. the vitamin in two con¬
trol subjects and four persons with pernicious anaemia. Four separ¬
ate isotopes—60Co, 58Co, 57Co, and 56Co—have been developed and used
?
for measuring vitamin B12 absorption. 60Co is no longer used because
TABLE I: Vitamin B12 Analogues
(5,6 dimethylbenziniinazolyl) cobamide cyanide -
CYANOCOBALAMIN
(5,6 dimethylbenzirainazolyl) aquocobamide -
AQUOCOBALAMIN
(5,6 dimethylbenziminazolyl) hydroxocobamide -
HYDROXOCOBALAMIN








of its very long half-life (1,290 days), and 56Co has fallen into
disuse, as the radiation dosage resulting from its use is high de¬
spite its relatively short half-life (77 days). 58Co (half-life 71
days) and 57Co (half-life 270 days) are now the isotopes of choice
for human studies; subjects receive a relatively low radiation dose
from 57Co, despite its somewhat long half-life, because it has a low
dose rate constant of gamma emission. Table II shows the radiation
doses to various organs from the four isotopes (Reizenstein 1959),
and Fig. 1 the scintillation spectra of the two most commonly used
isotopes, 58Co and 57Co (Armstrong and Woodliff 1966). These two
isotopes were used in the studies described below.
Dietary Content of Vitamin B12: Generally speaking, vitamin
B12, which does not occur in plants, is synthesised by bacteria, all
the vitamin B12 in higher animals deriving directly or indirectly
from this source. Though there is considerable synthesis of vita¬
min B12 by large bowel bacteria, this is of no nutritional value in
man, where large amounts, quantitatively similar to that found in
normal persons, may be found in the faeces of patients with vitamin
B12 deficiency due to the fish tapeworm (Kaipainen and Tctterman 1954)
or to pernicious anaemia (Berk et al. 1948, Bethell et al. 1948, Kai¬
painen et al. 1954). Man is thus entirely dependent on a dietary
intake of vitamin B12, the main sources of which are liver, kidney,
meats of all kinds, and dairy produce (McCance and Widdowson 1960).
TABLE II: Radiation Dose in Different Organs




60Co 58Co 57Co 56Co
Liver 2910 265 105 1465
Bone Marrow 730 60 28 300
Ovaries 245 25 12 120
Testes 600 55 14 185
(From: Reizenstein, 1959)




However, although it is possible to eat a vegetarian diet deficient
in vitamin B12, so widespread is the vitamin that it is rare for gross
deficiency states to occur for dietary reasons. Chung et al. (1961)
have shown that although the vitamin B12 content of diets of otherwise
widely varying quality differed greatly, even diets classified as of
poor general quality probably contained sufficient vitamin B12 (mean
2.7ug/day) to prevent deficiency syndromes even after cooking. In
addition to the wide distribution of the vitamin, however, deficiency
is also minimised by the relative lack of effect of cooking on the
vitamin (Banerjee and Chatterjea 1963) compared, for example, to folic
acid, and by the likelihood that almost all vitamin B12 ingestedris
equally available for absorption (Heyssel et al. 1966).
Human Vitamin B12 Balance: Many estimates have been made of
the total vitamin B12 content of the human body, either by microbio¬
logical assay of organs or by isotope dilution methods. These
estimates have given values ranging from a mean of about 5mg (Ross and
Mollin 1957) to one of about 2mg (Adams 1962). Vitamin B12 intake
from the diet varies greatly (Chung et al. 1961), as mentioned above,
and ranges from about 85jug daily on a high quality diet to ltig-on a
poor one. However, Heyssel et al. (1966) estimate that most normal
Western adults probably consume 5 to 15^ig daily of which 5ug at least
is absorbed. This daily absorption of vitamin B12 in normal persons
fits well with estimates of the daily obligatory losses of the vitamin,
probably mainly in the urine and stools (Hall 1964), which amount"to
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about 0.17a of the total body store daily (Heyssel et al. 1966). As
the daily obligatory vitamin loss varies with the total body store
(Reizenstein 1959), it has been suggested that the minimal daily
intake needed to maintain health in the absence of factors leading
to increased demand,such as growth and pregnancy, is 0.6-1.2pg/day
(Heyssel et al. 1966).
VITAMIN B12. ABSORPTION
It is generally recognised that vitamin B12 can be absorbed
in two ways! first by a process of diffusion across the small
intestinal wall, and second through a mechanism mediated by the
gastric product, intrinsic factor, in which the absorption of the
vitamin in the small intestine is limited to the terminal ileum.
Only the intrinsic factor mediated mechanism will be considered, as
the diffusion mechanism does not occur under normal circumstances.
INTRINSIC FACTOR
In a now classical series of papers (Castle 192.9, Castle
and Townsend 1929, Castle et al. 1930), Castle and his co-workers
at Harvard University discovered the existence of "intrinsic factor"
and laid the groundwork which has led to the present voluminous
literature on vitamin B12 and its absorption, These discoveries
were made in patients with pernicious anaemia who by 1929 were known
to have atrophy of the gastric glands and to have gastric juices inca¬
pable of digesting protein (Fenwick 1870) and who had been shown to
respond therapeutically to raw liver (Minot and Murphy 1926). The
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Harvard workers showed that marked improvement in pernicous anaemia
could be obtained by feeding patients beef muscle which had been
incubated with normal gastric juice, though neither alone could
achieve this effect. They showed that the effect could not be
mimicked by hydrochloric acid or commercial pig pepsin, was not
dependent on an acid pH, and could be destroyed by heating. Finally
they demonstrated that only normal gastric juice or gastric mucosa
possessed what they called the "intrinsic factor", needed to allow
the absorption into the body of the "extrinsic factor" in beef
muscle,now known to be vitamin B12. "Intrinsic factor" was not
present in saliva'or duodenal contents, where the latter were free
of contamination with gastric juice, nor was it present in the
gastric juice of patients with pernicious anaemia.
Vitamin B12 Binders in Gastric Juice: The binding of vi¬
tamin Bl2 is recognised as one of the fundamental properties of the
intrinsic factor in gastric juice. However, it is known that vita¬
min B12 binders other than intrinsic factor are present in gastric
juice, and these will not promote vitamin B12 absorption. The
nature of all the vitamin B12 binders in gastric juice has been in¬
vestigated predominantly by the groups of Grasbeck (1962) and of
Glass (1963). There are three vitamin B12 binders in gastric juice,
and these have received various designations. In pooled gastric
juice collected after betazole stimulation Simons (1964) found that
intrinsic factor (binder S, primary binder) constituted 63% of the
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binders, altered intrinsic factor (binder I, secondary binder) 19%,
and non-intrinsic factor binder (binder R, tertiary binder) 18%, The
relative amount of non-intrinsic factor binder is higher in fasting
gastric juice and falls when gastric secretion occurs. Gullberg and
Olnagen (1959) and Simons (1964) showed that the altered intrinsic
factor binder could be eliminated by in vivo neutralisation of gastric
juice, and it has also been shown that this binder is absent from
achlorhydric gastric juice (Glass et al. 1962, Simons 1964); it is
probably produced by the action of pepsin on intrinsic factor.
There are, therefore, basically two vitamin B12 binders in
gastric juice: intrinsic factor and non-intrinsic factor binder. A
very important practical implication of this is that gastric juice
vitamin B12 binding capacity cannot be equated with its intrinsic
factor content. In this regard,.it is pertinent to note that intrin¬
sic factor antibodies derived from persons with pernicious anaemia do
not react with non-intrinsic factor binder. The non-intrinsic factor
binder will, however, react with antisera to the vitamin B12 binder
found in saliva (Simons 1964).
Isolation of Human Intrinsic Factor: Human intrinsic factor
has been isolated in greatest purity by Grasbeck et al. (1966).
This was achieved, with 40 liters of pepsin-inactivated gastric juice,
using the methods of ultrafiltration for concentration followed by a
variety of chromatographic techniques. Analysis, by ultracentrifuga-
tion and by electrophoresis, of the intrinsic factor (binder S)
fraction showed it to be homogeneous, to have a molecular weight of
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119,000, to be a glycoprotein, and to be able to bind 25pg of vitamin
B12 per mg of protein. This latter fact suggested that two molecules
of vitamin B12 were being bound per molecule of intrinsic factor.
However, as previous work had suggested that intrinsic factor had a
molecular weight of 60,000, the authors suggested that their material
was in fact an intrinsic factor dimer. Thus one molecule of intrinsic
factor would bind one molecule of vitamin B12.
Fhysiccchemical Characteristics of Intrinsic Factor: Intrinsic
factor is known to have a number of properties which are important in
relation to its biological activity and xrfiich it is important to be
aware of in work involving its estimation. Castle et al. (1937) ori¬
ginally observed the thermolability of intrinsic factor after exposure
to 100°C for five minutes, and since then it has been shown that ther¬
molability occurs at even lower temperatures. Intrinsic factor activ¬
ity has been found to be stable between pH 2.0 and pH 10.0 (Grasbeck
1956), though activity is rapidly lost above pH 10.0 (Castro-Curel and
Glass 1963). Intrinsic factor is also destroyed by pepsin (Grasbeck
1956), and the vitamin B12 binding capacity of acid gastric juice falls
steadily, this being much less at room temperature than at 37°C (Abels
and Schilling 1964). The molecule, however, seems to resist the action
of a number of other enzymes, including trypsin, papain, and tyrosinase.
In all of the work cited above, intrinsic factor activity was
measured, either in vivo or in vitro by its ability to promote vitamin
B12 uptake by ileal preparations. In 1963 the radioimmunoassay for
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intrinsic factor was introduced (Ardeman and Chanarin 1963), This
assay has been very widely used since then and was used in the work
described below. There have been very few reports on the effects of
factors such as temperature, pH, and pepsin on immunoassayable in¬
trinsic factor, and none of it was available when this work was
started. McGuigan (1967) has since shown that the affinity constant
of vitamin B12 for intrinsic factor is very high and does not alter
between pH 4.5 and pH 11.0 in depepsinized gastric juice. According
to Irvine (1966), the intrinsic factor content of normal human gastric
juice is unaltered by a pH of 2.0 for two hours at room temperature
but is destroyed after thirty minutes at 56°C. The former finding is
in contrast to that of Ashworth et al. (1969), who found a prompt and
marked reduction in intrinsic factor content in acidic gastric juice;
these workers provided evidence that the loss was due to the action of
pepsin. The present author's experience is based on experimental
work described later, but in summary, while intrinsic factor was stable
at pH levels from 2.1 to 10.0 and at temperatures from 4°C to 37°C in
depepsinized gastric juice, a reduction of pE in the presence of pepsin
at 37°C resulted in a prompt loss of intrinsic factor.
Production and Secretion of Intrinsic Factor: Until recently
it was known only that intrinsic factor was produced in the fundus of
the human stomach. This was based on the observations that atrophic
gastritis in pernicious anaemia was confined to the fundus (Magnus "and
Ungley 1938) , the normality of the antrum in that condition being
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confirmed by recent work on gastrin secretion (Strickland et al.
1971), that proximal gastrectomy gave rise to vitamin B12 malab¬
sorption almost as often as total gastrectomy which will always pro¬
duce malabsorption, and that only preparations from the fundic part
of the stomach will promote vitamin B12 absorption efficiency in
pernicious anaemia (Posth et al. 1962). In 196*4 however, Hoedemaeker
et al. demonstrated by immunoautoradiographic methods that in man the
parietal cell is the source of intrinsic factor. As the parietal
cell is also the source of hydrochlorhydric acid, this discovery led
to many studies of the secretion of intrinsic factor, particularly in
relation to acid secretion and in response to agents known to stimu¬
late acid secretion. In general, it has been found that men secrete
more intrinsic factor than women both in the basal state and after
gastric secretory stimulation, and that this is solely the result of
the greater gastric juice volume produced by the former, intrinsic
factor concentrations being the same (Ardeman et al. 1965). In older
persons over the age of 50 years intrinsic factor secretion falls. It
has been shown that there is a considerable secretion of intrinsic
factor even in the basal state (Ardeman et al. 1964) with average hour¬
ly outputs of 3000ng units, and that any of those substances known to
be potent stimulators of acid secretion, such as histamine (Ardeman et
al. 1964, R?5dbro et al. 1965), histalog (Ardeman and Chanarin • 1965)
gastrin (Wangel and Callender 1965, Irvine et al. 1965), pentagastrin
(Shearman et al. 1967, Irvine et al. 1968), and insulin (Ardeman et al.
1964), will cause a marked increase in intrinsic factor secretion. The
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absolute amounts of intrinsic factor secreted after stimulation
vary, and much of the variation can probably be attributed to the
varying completeness of gastric juice collections in different
reports. The extent to which different gastric stimulants give
comparable results on intrinsic factor secretion has been much less
studied. In the work described below,two different powerful stimu¬
lants, histamine and pentagastrin, were used for reasons detailed
later. It had previously been shown by others that histamine
(0.04mg/kg of body weight) and pentagastrin (6jjg./kg of body weight)
gave comparable acid secretory responses (Makhlouf et al. 1966, Wortn-
sley et al. 1966, Multicenter Pilot Study 1967, Kcntureck 1967), and
the studies of the author and his colleagues showed that in these doses
the two agents had closely similar effects on intrinsic factor secre¬
tion (Shearman et al. 1967). These studies also illustrated the very
significant correlation known to exist between acid and intrinsic
et al.
factor secretion (Ardeman 1965, R^dbro^l965), and showed the different
secretion patterns for the two substances (see Figs. 11 and 12 in"Mater-
ial and Method^') when continuous gastric secretory stimulation is given
(Dotevall et al. 1967). These patterns suggest that whereas acid is
produced only in response to stimulation, intrinsic factor is stored
and gives a "wash out" pattern on stimulation.
Assay of Intrinsic Factor: Intrinsic factor may be assayed
either in vivo or in vitro. The in vivo methods, which depend on
demonstrating that a material will promote vitamin B12 absorption in
12
a subject with pernicious anaemia, are cumbersome and time consum¬
ing but have the advantage of demonstrating capacity to cause
actual absorption. They do not give quantitative results. The
in vitro radioimmunoassay is by far the best method currently avail¬
able for measuring human intrinsic factor, and the most accepted
simple method giving reproducible results is that of Ardeman and
Chanarin (1963). This assay, which was used in the work described
below, depends on the use of specific antibody to intrinsic factor
and the vitamin B12 absorbent charcoal.
INTRINSIC FACTOR-VITAMIN Bl2 INTERACTION
As described above, Grasbeck et al. (1966) have suggested that
each molecule (monomeric) of intrinsic factor binds one molecule of
vitamin B12, and McGuigan (1967) has demonstrated its great avidity
for the vitamin. The union of intrinsic factor and vitamin B12 occurs
very quickly and as the molecule becomes smaller, as defined by gel
filtration and sedimentation studies, after binding to vitamin B12,
Grasbeck (1967) has suggested that the intrinsic factor molecule
folds round the vitamin B12 molecule. The nucleotide and the corrin
ring of the vitamin B12 molecule seem to be of greatest importance in
the union with intrinsic factor, the ligand being of relatively little
importance. It has been shown that exchange between bound and un¬
bound vitamin B12 occurs both in vivo and in vitro, and in vitro this
is temperature dependent. Once bound to vitamin B12, human intrinsic
factor becomes more resistant to the destructive effects of heat and
pepsin (Abels and Schilling 1964). On the other hand, the binding of
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vitamin B12 to intrinsic factor may prevent the uptake of the
former by some of the bacteria likely to be found in blind-loop
syndrome (Donaldson et al. 1962).
ILEAL ABSORPTION OF VITAMIN Bl2
It is now fully accepted that in humans, physiological
vitamin B12 absorption is restricted to the terminal two to six-
feet of the ileum. For normal absorption to occuti however, "not
only must the ileal epithelial cells be healthy, but the luminal
small intestinal environment must also be normal. Disturbances"
in the latter, such as excess acidity, as in the Zollinger-Ellison
syndrome, lack of"pancreatic exocrine secretion, or the excessive
local proliferation of bacteria, may cause this. In this review
of normal absorption,however, these factors will not be considered
further.
When an oral dose of radioactive vitamin B12 is given,
detectable vitamin B12 does not appear in the blood for four hours
and does not reach a peak for some eight to twelve hours (Booth arid
Mollin 1956). It has been found that this long delay is due to the
time needed for the vitamin B12 to pass from the epithelial cell "sur¬
face into the body. Much of current research centers on the mechanism
aV '' i
of this absorption,which is still largely unknown. That "there must
- - -
--CQ
be a specific mucosal receptor site is indicated by the anatomical'
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restrictions of the absorption area and the ease with which the in¬
trinsic factor absorption mechanism can be saturated. Donaldson et
al. (1967) demonstrated that in hamsters the specific receptors
may be in the microvillous membranes of the villous epithelial
cells, and later work from the same group (Mackenzie et al. 1968)
showed that these sites could be blocked by antibody to distal but
not to proximal epithelial microvillous membranes. In humans it
has been shown that only ileal homogenates will show an enhanced
intrinsic factor-vitamin B12 uptake which can be blocked by in¬
trinsic factor antibody (Carmel et al. 1969). Although uptake of
the intrinsic factor-vitamin B12 complex may not require a source-'
of energy, the available evidence suggests that the presence of-
calcium or magnesium ions is needed and that the process occurs
best at pH6.6 (Cooper and Castle 1960, Carmel et al. 1969).
It is currently considered that the transfer of vitamin -~-r-
B12 across the ileal cell requires that it be separated from in- - -
trinsic factor, as the latter has not been identified in associa-- °"
tion with absorbed vitamin B12 reaching the intestinal lymphatics
in rats (Boass and Wilson 1964) or the portal blood in man (Coope*r ~
and White 1968). The work of Peters and Koffbrand (1970) in -
guinea pigs using 125 I-labelled intrinsic factor and 57Co vitamin-""
B12 support this idea, as only the vitamin B12 entered the cell.
The separation of the complex preceded the period of delay in -S
absorption, and it has been supposed that separation may be effected"
by brush border hydrolase enzymes (Mackenzie and Donaldson 1S69)-;-"
Peters and Hoffbrand (1971) also showed that the vitamin B12 passesec
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to the mitochondria before entering the body. What happens to the
vitamin B12 in the ileal epithelial cell is not known, but it event¬
ually enters the blood attached to a carrier protein, transcobalamin
II (Hall and Finkler 1965). This carrier has a very short half-life
(Hall 1969)> so that the vitamin B12 quickly reaches the tissues.
BODY DISTRIBUTION OF VITAMIN B12
Absorbed radioactive vitamin B12 enters the plasma bound to a
j3> globulin, transcobalamin II (Hall and Finkler 1965). This has a
very short half-life, and there is evidence that transcobalamin II,
which is probably produced by the liver (Haught et al. 1967), may
promote vitamin B12 uptake by cells (Finkler and Hall 1967), Little
of the vitamin reaches the urine (see "Results" below). Later, vita¬
min B12 re-enters the plasma bound to an o(globulin, transcobalamin I
(Hall and Finkler 1965), which does not promote cell uptake of the
vitamin (Finkler and Hall 1967); it has been suggested that trans¬
cobalamin I is a cell-exit vitamin B12 carrier (Finkler and Hall 1967).
Over the first week after absorption there is a rapid rise in hepatic
radioactivity followed by a more gradual rise due to a slow but contin¬
uous further transfer to the liver. Final equilibration from a single
oral dose may take about one month (Bozian et al. 1963).
Absorbed vitamin B12 is re-excreted in the bile, and this
appears to be the major source of excretion from the body (Araeman et
al. 1965). Relatively little of this biliary excretion of vitamin
B12 reaches the faeces, however, some three quarters being reabsorbed
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(Grasbeck et al. 1958). Vitamin B12 excreted in bile requires
intrinsic factor for its reabsorption (Booth and Spray 1960).
LIMITS OF VITAMIN B12 ABSORPTION
There is a limit to the amount of vitamin B12 which can be
absorbed from a single oral dose, and beyond the limit there is a
refractory state to further uptake. This refractory state proba¬
bly lasts for less than 4 hours (Heyssel et al. 1966). It has
been suggested (Swenseid et al. 1954) that the mean maximum absorp¬
tion for any one dose is about 1.6ag, though individuals may absorb
up to 3.0pg. Swenseid et al. (1954) found that some subjects, espe¬
cially those who absorbed relatively little in the fasting state,
absorbed more when the test dose was given with a vitamin Bl2-free
meal. This has been found to occur more often in persons following
partial gastrectomy (Deller et al. 1961, Turnbull 1967). On the
other hand, Heyssel et al. (1966) found that natural dietary vitamin
B12 and an aqueous solution of vitamin B12 were equally well absorb¬
ed in normal persons. These last investigators suggested that vita¬
min B12 absorption may diminish with age (Heyssel et al. 1966).
It has been estimated that 400-500ng units of intrinsic
factor are needed to allow normal absorption from lug of vitamin B12,
though more may be required after gastric surgery (Ardeman and
Chanarin 1965).
SUMMARY
Vitamin B12 and its analogues are a group of substances which
comprise a ccrrin ring, a nucleotide^ and a ligand the nature of which
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varies. Deoxyadenosylco'balamin is the most important form occurring
in nature, where all vitamin B12 derives from bacterial synthesis.
The main sources of vitamin B12 are animal protein products, and the
daily minimal requirement for the vitamin in humans is about 0.6-1.2^ig.
Normal absorption of vitamin B12 requires the production of in-
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trinsic factor, which is secreted simultaneously with acid by the gas¬
tric fundal parietal cells in man. Intrinsic factor is a thermola-
bile glycoprotein, susceptible to the proteolytic action of pepsin,
which will bind one molecule of vitamin B12 per molecule of intrinsic
factor and promote its absorption from the intestine. This latter
property distinguishes intrinsic factor from other vitamin B12 bind¬
ers produced by the stomach.
Vitamin B12 is absorbed solely in the terminal ileum in man,
and specific receptor sites there seem to determine this function.
The uptake of the vitamin at any given time is limited, and many ab¬
normalities of the intestinal luminal environment may interfere with
this. In the terminal ileum, vitamin B12 seems to be separated from
intrinsic factor at the epithelial cell surface, only the vitamin B12
entering the cell. A number of unknown metabolic processes occur
within the ileal epithelial cell, perhaps in the mitochondria, before
the vitamin B12 enters the body, where it is bound to a plasma protein,
transcobalamin II, which promotes its uptake by tissues.
It appears that most forms of vitamin B12 are well absorbed,
and food vitamin B12 is absorbed as well as aqueous cyanocobalamin.
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DEFINITION OF PERNICIOUS ANAEMIA
The definition of pernicious anaemia is central to a close
consideration of the results obtained with any test designed to
measure vitamin B12 absorption. The reason for this is that perni¬
cious anaemia is one disease in which severe malabsorption of the
vitamin should always be found by definition. In other conditions
such as partial gastrectomy, coeliac syndrome and Crohn's disease,
severe vitamin B12 malabsorption may occur, but is by no means
universal. Consequently, the basic first assessment of a vitamin
B12 absorption test is to see whether it can differentiate between
subjects without gastrointestinal disease and those with pernicious
anaemia. The only other condition which can replace pernicious
anaemia for such a purpose is where a subject has had a total gas¬
trectomy; this, however, is an operation which is rarely done, and
no such subjects were available for the study described below.
The term pernicious anaemia is frequently used incorrectly
to refer to vitamin B12 deficiency megaloblastic anaemias following
partial gastrectomy or due to congenital ileal vitamin B12 mal¬
absorption (Grasbeck et al. 1960, Imerslund 1960). In fact; it may be
defined as vitamin B12 deficiency resulting from malabsorption of
vitamin B12 owing to absent, inadequate or ineffective intrinsic
factor secretion by the intact stomach. The question as to what is
inadequate intrinsic factor secretion in quantitative terms is the
subject of a dispute which is discussed below. However, in this
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study subjects were accepted as having pernicious anaemia if they
had intact stomachs and malabsorption of vitamin B12 which could be
corrected fully with exogenous intrinsic factor as assessed by the
Schilling test (see "Materials and Methods"). Phenomena such as
parietal cell antibodies and intrinsic factor antibodies which occur
in pernicious anaemia were looked for, but as they are not central
to the diagnosis, they were not taken into account in this regard.
METHODS FOR THE MEASUREMENT OF VITAMIN B12 ABSORPTION
All generally accepted methods for measuring vitamin B12
absorption at the present time depend on the use of radioactive
isotopes, and these assays "compare with the hematological assays
of the past as a 1963 leisurely motor drive from Marathon to Athens
compares with the Marathon run of the old Greeks" (Glass 1963). At
the present time five different isotope methods have been developed
for this purpose, and these depend on the measurement of faecal,
urinary, plasma, hepatic or whole body radioactivity, under specific
circumstances, after the administration of test doses of the iso-
topically labeled vitamin. In this section, the advantages and dis¬
advantages of the first four methods will be reviewed, after which
the principles of whole body counting and the work done so far on
their application to measuring vitamin B12 absorption will be stated.
Faecal Excretion Test.
Heinle et al. (1952), who were the first to demonstrate
intrinsic factor dependent malabsorption of vitamin B12 in pernicious
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anaemia, did so using this test. They found that when given 0.5^ig of
6OC0 vitamin B12, three persons with pernicious anaemia absorbed 4-28%
of the test dose, and that this could be raised to 71-95% with added
hog intrinsic factor; two control subjects absorbed 58-100% of this
test dose.
The principle of the test is to give a test dose of vitamin
B12 orally, collect the faeces until excretion of radioactivity ceases,
and derive the amount absorbed from that found in the faeces. It is
assumed that faecal radioactivity represents excreted vitamin B12,
that this excreted vitamin B12 was not absorbed, and that the differ¬
ence between ingested and excreted radioactivity represents that
amount of vitamin B12 absorbed into the body. As Glass (1963) has
stated, there is the possibility that some faecal radioactivity may
represent vitamin B12 re-excreted in the enterohepatic circulation and
not reabsorbed, and that unabsorbed radioactivity may be trapped for a
considerable time in, for example, diverticula and be counted as ab¬
sorbed. Most workers agree that excreted radioactivity truly repre¬
sents vitamin B12 and accept that this is a valid test method.
The test has three main advantages: it is potentially quanti¬
tative; no parenteral vitamin B12 is given, so that metabolic and
haematologic changes resulting from this do not occur; and it is not
invalidated by renal failure. On the other hand, the test takes a
long time to perform, is aesthetically distasteful to most subjects,
resulting in frequently poor faecal collections (see "Discussion"
*
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below), and has a poor reproducibility with a wide normal absorption
range which may overlap with the malabsorption range (Glass 1963).
The results obtained in the faecal excretion test depend on
the dose of vitamin B12 given. Very variable doses have been used
by different workers, and this has been criticised by Grasbeck
(19651). For example, the work of a variety of centers showed that
the calculated normal absorption from a O.S^ig dose was 20-95%, from
a l.Ojig dose 26-88%, and from a 2.0-ug dose 4-83% (Glass 1963).
Where workers have used a 0.5ug dose, as in the work described be¬
low, the range of absorption in pernicious anaemia has been C-28%
as compared to 20-95% in controls (Heinle et ai. 1952, Callender
et al. 1954, Halsted et al. 1956). When intrinsic factor was given
to the pernicious anaemia patients in these series, the absorption
range rose to 34-95%. It can be seen that there is seme overlap in
these ranges.
In 1965 Ganatra et al. introduced a double isotope method
in an attempt to simplify the faecal excretion test while retaining
it as a quantitative test of absorption. They used the nonabsorbable
gastrointestinal marker 51Cr (Whitby and Lang 1959) as chromic oxide
and showed that the percentage absorption from a dose of 58Co vitamin
B12 could be calculated from single stool specimens taken within the
first 48 hours after both isotopes had been given together. This
was done from the formula:
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100 (5lCr in standard x 58Co in stool)
Absorption (%) = 100 -
5lCr in stool x 58Co in standard
Moreover, single stool specimens collected within the 48 hour
period gave closely similar results. Mollin and Walters (1967)
were unable to reproduce the promising results of Ganatra et al.
(1965), but more recently good results have been reported by
Campbell and Craswell (1970). These last workers used fluid 5lCr
chromic chloride as the marker and suggested that this may give
better results than insoluble 51Cr chromic oxide, the gut dispersal
of which probably differs from that of fluid 58Co vitamin B12,
In summary, most workers agree that the faecal excretion
test is a valid way of measuring vitamin B12 absorption quantita¬
tively, albeit indirectly. The main drawback is the high incidence
of incomplete collections of faeces due to the unaesthetic nature
of the test, though this problem may be made easier by the use of
double isotope methods.
Urinary Excretion Test.
The urinary excretion test depends on the observation that
the majority of a large dose of nonradioactive vitamin B12 passes
rapidly into the urine, 80% of it being excreted within 24 hours.
During this period it carries with it a substantial part of any radio¬
active vitamin B12 absorbed simultaneously into the blood from the gut.
It has been shown that the radioactivity in the urine truly represents
vitamin B12 (Maclean and Bloch 1954), that about a third of the radio-
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activity absorbed in normal persons is carried into the urine in
the 24 hour period (Callender and Evans 1955, Cottrall et al. 1971),
though this is less where there is malabsorption, and that the peak
excretion of radioactivity occurs between the sixth and twelfth
hours.
This test was originally described by Schilling (1953), and
in its original form a test dose of 2.0pg was given with the so-
called "flushing" dose of unlabelled vitamin B12 being given intra¬
muscularly two hours later. Urine was collected over a 24 hour
period and the excreted radioactivity expressed as a percentage of
that given orally. Since 1953 this test, which has become the most
widely used one in clinical practice, has been variously modified as
regards the oral test dose, the interval between giving the oral
test dose and the nonradioactive "flushing" dose, the number of
"flushing" doses, the duration of the urine collection, and the way
of counting urine radioactivity. The results of all these modifica¬
tions can be summarised by saying that higher percentage excretions
of radioactivity are obtained by lowering the amount of the oral test
dose, increasing the number of "flushing" doses, and prolonging the
urine collection time over that stated above. Glass (1963) has il¬
lustrated this by summarising the reports of various workers. Where
a test dose of 2.0pg of radioactive vitamin B12, one "flushing" dose
of l.Omg of nonradioactive vitamin B12, and a 24 hour urine collec¬
tion period were used, normal excretion ranged from 10% to 16%; when
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the respective criteria used were a test dose of less than l.Oug,
one "flushing" dose, and a 24 hour collection period, normal excre¬
tion was 15-26%; with two "flushing" doses and 48-72 hours of urine
collection, normal excretion was 30-37% from a test dose of less
than l.Opg and 13-18% from a 2.0ug test dose. Even when 72 hour ex¬
cretion values are used, patients with pernicious anaemia usually
excrete only up to 8% of the test dose, with mean values of 0.4-3.8%.
More than one "flushing" dose does not increase excretion of radio¬
activity in pernicious anaemia, and overlap between pernicious anae¬
mia and normal subjects is uncommon whatever methodological variant
is used. When potent human or hog intrinsic factor was added to the
test, this markedly increased, but did not always rectify completely,
absorption in pernicious anaemia. These results have been confirmed
by more recent workers (Lamar et al. 1965).
Relatively little work has been done on the reproducibility
in the same subject of any of the vitamin B12 tests described. It
is therefore important to note that Adams and Cartwright (1963) have
questioned the validity of single urinary excretion tests, at least
in patients with intestinal malabsorption or in those who have had
partial gastrectomy. They found consistently normal or subnormal
values in only one of seven malabsorptive patients and in only two
of eight patients with partial gastrectomy. The reasons for the vari¬
ability were not determined, but the importance of their findings is
clear.
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Katz et al. (1963) modified the urinary excretion test by in¬
troducing a double isotope test for the detection of intrinsic factor
mediated vitamin B12 malabsorption. These workers, who gave 6OC0
vitamin B12 bound to normal human gastric juice and free 57Co vitamin
B12 orally at the same time, were able to show a clear separation be¬
tween the ratios of the isotopically labeled vitamin which had been
bound to intrinsic factor and that which had not in the 24 hour
urine specimen in controls (0.97: range 0.83 - 1.16) and patients
with pernicious anaemia (2.60: range 1.61 - 3.63). This work was
confirmed by Bell and Lee (1969), using 57Co and 58Co, who also
showed that circulating serum intrinsic factor antibodies in six
pernicious anaemia patients did not seem to inhibit the absorption
of the intrinsic factor bound 57Co vitamin B12. Although Glass (1963)
suggested that exchange of the bound and free isotopes in the gut
might invalidate this form of the test, in practice this does not seem
to have happened.
The clinical value of this test is universally acknowledged,
and this is reflected in its being the test which is most widely used.
It is simple from the clinical and laboratory viewpoints, relatively
rapidly done, and at least in pernicious anaemia seems consistently to
differentiate between controls and persons with malabsorption. The
flushing dose also removes about a third of the absorbed radioactivity
in persons with normal absorption. On the other hand, from a research
point of view it has the drawbacks of being only qualitative or at most
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semiquantitative, of needing subjects who can co-operate in urine
collection, and of altering vitamin B12 metabolism and the haemato-
logical picture as a result of giving the "flushing" vitamin B12
dose. It may also underestimate vitamin B12 absorption, as seme
of the "flushing" dose may be excreted in the bile into the gut>
where it could reduce the absorption of intrinsic factor bound
radioactive vitamin B12 by exchanging with the latter. Finally,
et al.
the test is invalid in the presence of renal impairment (Rath^I957).
Hepatic Uptake Test.
This test, originally described by Glass et al. (1954) is
based on the knowledge that a large proportion of an oral test dose
of radioactive vitamin B12 absorbed from the intestine is deposited
in the liver. Surface scintillation counting of radioactivity is
carried out one week after the administration of the oral test dose
to allow time for the excretion of unabsorbed radioactivity, and to
allow peak accumulation of radioactivity in the liver to occur. The
test can be done two days after the oral dose is given if unabsorbed
radioactivity is actively removed from the bowel (Glass and Boyd 1957).
Counts are carried out over two or three liver projections, and
corrected for background (obtained by a calf count) and decay of
activity. Attempts are made to detect unabsorbed radioactivity by
counting over the left iliac fossa, count rates in this region ex¬
ceeding 507» of the liver count rate indicating unabsorbed and unex-
creted material.
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Many modifications have been made to the original test,
including the use of large scintillation crystals (Johnson et al.
1958) , very high specific activity 56Co vitamin B12 (Booth and
Mollin 1956), and the use of single projection counts (Pollycove and
Apt 1956). All of these methods seem to give satisfactory results
for routine clinical purposes, and there is virtually no overlapping
between control subjects and those with pernicious anaemia or total
gastrectomy. Typical results are quoted by Glass (1963) in his re¬
view of this topic. Using a 0.5pg test dose of vitamin B12, healthy
persons had liver counts of 200-5300 counts/min/pc of the oral dose,
pernicious anaemia patients 0-769 counts/min/pc, and after intrinsic
factor the counts in the latter group rose to 120-3587 counts/min/pc.
This test has many advantages when looked at from the clin¬
ical viewpoint. It does not require urine or stool collections,
the taking of blood is unnecessary, and renal disease does not inter¬
fere with it. No "flushing" doses of vitamin B12 are given and so
subsequent patient investigations are not made void. It is simple,
and results generally clearly separate those with normal absorption
from those with pernicious anaemia. On the other hand, owing to
difficulties in establishing baselines consequent on the .accumulation
of radioactivity in the liver, repeated absorption tests with this
method may be difficult. Furthermore, coexistent liver disease may
decrease the amount of radioactivity in that organ (Glass et al. 1958).
This impaired uptake cannot be reversed by intrinsic factor. Finally,
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Townsend et al. (1968) have commented on the poor reproducibility of
this test and on the wide range of normal absorption.
More recently, Weisberg and Glass (1966) have reported on
their efforts to make the hepatic uptake quantitative. This was done
by using a double isotope method in which 0.5jug of 60Co vitamin B12
was given orally and O.ljag of 57Co vitamin B12 was given intravenously.
The percent absorption of the oral dose was calculated from the formula
oral dose hepatic counts
x 100
intravenous dose hepatic counts
The method assumes that the tissue distribution of orally and intra¬
venously administered vitamin B12 is the same, for which there is evi-
et al.
dence (ReizensteinA1963), and correction factors have to be introduced
to allow for the different counting efficiencies of 60Co and 57Co.
The authors consider the method is quantitative and claim that, as
ratios are used,it eliminates the difficulties of varying liver geome¬
try in different subjects and the problem of poor liver function in
those with significant liver disease.
Plasma Radioactivity Test.
This test, though in no way quantitative, has the advantages
of simplicity: there is no need for urine or faecal collections and
a result is obtained in less than 24 hours. Similar curves for plasma
radioactivity have been obtained by all workers, and it is now recog¬
nised that for clinical purposes a single 8 hour plasma sample is all
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that is needed. The test can be done without giving "flushing"
doses of vitamin B12, though Coupland (1966) and others have shown
that this greatly increased plasma activity levels. The test can
be used in the presence of renal failure.
At first the test did not gain wide acceptance in spite of
its simplicity, because relatively large amounts of then-used iso¬
topes such as 56Co (Booth and Mollin 1956) and 60Co (Doscherholmen
and Hagen 1957) were needed to produce rather low plasma activity
levels. With the introduction of 57Co, however, good plasma radio¬
activity could be obtained with relatively small oral test doses,
and the diagnostic discriminatory power of the test was improved by
the discovery that plasma radioactivity was increased by "flushing"
doses of vitamin B12 (Coupland 1966). Since then a number of re¬
ports have substantiated the claim that where 57Co vitamin 312 is
used, the test has good diagnostic value (Workman and Rusche 1966,
Forshaw and Earwood 1966, Finney and Payne 1568, Arkun et al. 1969),
though occasional unusual results are obtained (McIntyre and Wagner
1966, Coiner and Walsh 1971).
Correlation Between Tests.
Several workers have reported on the interrelation of results
obtained using more than one of the above tests on the same subjects.
There is somewhat limited value in trying to obtain linear correla¬
tions between tests that are not both quantitative, such as the urinary
excretion and plasma radioactivity tests; but in general it may be
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said that in the majority of instances there is good agreement in
the discrimination of normal absorption and malabsorption between
these four tests (Callender and Evans 1955, Pollycove and Apt 1956,
Woodliff and Armstrong 1966, Donaldson et al. 1970), though exceptions
have been noted (Mclntyre and Wagner 1966). An almost straight line
relation has been reported between the hepatic uptake and faecal ex¬
cretion tests (Pollycove and Apt 1956, Fone et al. 1961).
Summary.
Four methods of testing vitamin B12 absorption have been
described: the faecal excretion method, the urine excretion method,
the hepatic uptake method,and the plasma radioactivity method. All
four give satisfactory results for clinical purposes under optimal
conditions, though only the faecal excretion and perhaps the hepatic
uptake method can be considered as quantitative. The faecal excre¬
tion and hepatic uptake tests are subject to errors from counting
unabsorbed and unexcreted radioactivity; the faecal excretion and
urine excretion tests require the accurate collection of body excre¬
tions, which is often faulty; the urine excretion and plasma radio¬
activity tests involve giving large "flushing" doses of parenteral-
vitamin B12, which alter body metabolic processes; and the plasma
radioactivity test is wholly qualitative. There is on the whole a
satisfactory correlation between the results: obtained with these ^
different tests. -- ^ - .. ---
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VITAMIN 312 ABSORPTION TESTS WITH GASTRIC STIMULATION
In an attempt to improve the separation of absorption test re¬
sults in persons who can produce sufficient intrinsic factor to effect
vitamin B12 absorption from those in persons who cannot, a number of
workers have given gastric stimulants when carrying cut vitamin B12
absorption tests. The results of these efforts will be briefly de¬
scribed.
Carbachol.
Baker and Mollin (1955) originally reported that carbachol
0.25mg intramuscularly could increase the absorption of vitamin B12
in certain subjects with low absorption values. Some of these sub¬
jects had acid in the gastric juice and some did not, but none had
pernicious anaemia. Mcllin et al. (1957) confirmed these results
and showed that carbachol, given at the time of a faecal excretion
test, eliminated any overlap of results between pernicious anaemia
patients and control subjects; this occurred as carbachol increased
absorption only in the latter group. These workers suggested that
the effect resulted from a stimulation of intrinsic factor secretion
by carbachol; however, it has been shown more recently (Ardeman et
al. 1964, Schipperijn 1965) that carbachol does not cause secretion
of intrinsic factor. An alternative explanation is that carbachol
produces its effect by increasing bowel motility, thus carrying the
vitamin B12-intrinsic factor complex to the ileum before significant
proteolytic inactivarion has occurred. Whiteside et al. (1964) and
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Siurala et al. (1960) have shown that carbachol may increase absorp¬
tion in certain patients with atrophic gastritis. Dellipiani and
Seaton (1965), on the other hand, found no increase in absorption in
control subjects or postgastrectomy patients following the use of
carbachol.
Histamine and Pentagastrin.
Kanaghinis et al. (1968) have claimed that l.Omg of histamine
phosphate given intramuscularly half an hour before a urinary excre¬
tion test will increase absorption to the same extent as carbachol.
This certainly seemed to be the case in many instances, but the find¬
ing was far from universal. Irvine et al. (1970), on the other hand,
saw no consistent effect of either histamine or pentagastrin on
vitamin B12 absorption using the whole body counting method in sub¬
jects with or without pernicious anaemia. Armstrong and Woodliff
(1967) saw no effect of carbachol or gastrin in their group of perni¬
cious anaemia subjects.
Food.
Rune (1966) has shown that food is equivalent to histamine as
a stimulus to gastric acid and therefore to intrinsic factor secre¬
tion. This is of interest in that Swenseid et al. (1954) using the
faecal excretion test showed increased absorption of vitamin B12 in
seven normal subjects when the test dose (0.5pg) was given with a
meal. Deller et al. (1961) using the faecal excretion test were
unable to show this effect in control subjects or in those with
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pernicious anaemia, but round that food significantly improved
absorption after partial gastrectomy, a finding confirmed by
Turnbull (1967). Grasbeck et al. (1956) found that there was
no effect of food on vitamin B12 absorption when the vitamin
was given three hours after a meal.
In summary, carbachol seems to be able to increase vita¬
min B12 absorption in some subjects with low absorption values
by an unknown mechanism. This does not occur in pernicious
anaemia. Food, which stimulates gastric secretion, can also
do this, especially after partial gastrectomy, and histamine or
pentagastrin may do it occasionally in individual subjects.
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WHOLE BODY COUNTERS
In this section the types of whole body counters available will
be mentioned and the broad principles governing the use of that em¬
ployed in this study described. Whole body counters, which are also
known as low-level radiation counters, are instruments designed to de¬
tect minute amounts of radioactivity in human subjects. Currently
there are two principal types available: liquid scintillation counters,
which have high counting efficiency and sensitivity but limited gamma-
ray energy resolution, and solid crystal counters, which are slower
and less sensitive but have much higher resolution of gamma-ray spectra,
permitting precise identification of different nuclides. Because of
their inherent versatility, solid crystal counters have been widely
accepted and are very suitable for the type of tracer studies reported
here.
In general, whole body counters used in work with humans com¬
prise a structure to hold the subject in position for counting, a de¬
tector to detect gamma radiation emitted by the subject, a mechanism
for counting the radiation detected, and some means for excluding, or
greatly reducing, extraneous (background) radiation.
The geometry of the position in which the subject is held
for counting is of some importance, particularly as no one geometry
is best under all circumstances. There are three commonly used
geometries: the tilting chair, the arc bed (the arc generally be¬
ing of one meter), and the scanning bed, in which the detectors
scan over the subject. In general, when redistribution of ad¬
ministered isotopes occurs in the body, counting rates vary
considerably if the tilting chair geometry is used (Price et al.
1962, Naversten 1964), and this is particularly the case where
the isotope tends to accumulate in certain organs, as is the case
with vitamin B12. Naversten (1964), using phantoms, showed that
a relative response of 0.8-2.0 for the same radioactivity con¬
centrated in different sites could be reduced to 0.95-1.15 by a
scanning system. The satisfactory performance of the scanning
system, used in the present work, has been demonstrated for
radioactive vitamin B12 in practice (Callender et al. 1966).
The whole body counter used in this study had thallium-
activated sodium iodide crystals as detectors of radiation. When
a gamma ray of the energy range utilized in medical applications
(under 2.0 Mev) interacts with matter, it is usually by collision
with an electron, and some or all of its energy is transferred to
that electron. In certain materials, such as thallium-activated
sodium iodide crystals, the energy reappears instantly as photons
of visible or ultraviolet light, which can be detected and con¬
verted to electrical pulses by a photomultiplier tube. These
crystals are generally hermetically encapsulated in aluminum
except for one surface, which is optically coupled to the photo-
multiplier tube via a lucite light pipe and a silicon seal. The
interior surfaces of the aluminium can are coated with a diffusely
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reflecting material such as titanium dioxide, so that all of the
light from a scintillation pulse reaches the photomultiplier
tube. The height of the output pulse of the photomultiplier is
proportional to the energy deposited in the crystal by the inci¬
dent gamma ray. One or more electronic gates, known as spectrom¬
eters, can be used to sort the pulses and pass on only those due
to total absorption of gamma rays emitted by the isotope it is
desired to detect. These pulses can be counted by a scaler, or
a ratemeter can be used to display the average number of pulses
received in a given time interval. A single channel pulse height
analyzer was used to determine the energy spectrum counted in this
study, and a ratemeter was used to count the pulses during profile
s canning.
An unshielded scintillation counter crystal will detect
background radiation, which comprises that derived from outer
space (cosmic radiation) and that from the natural radioactive
contamination of the surroundings. The background radiation may
make the detection of low levels of radioactivity in a subject
difficult. This problem can be eliminated by placing the counting
apparatus in a standard low background steel room, but this entails
the use of a shield weighing some 20 to 50 tons. In clinical work,
however, the shielding requirements are not generally so great, as
doses of up to a microcurie of gamma-emitting radioisotope can be
used. Hence partial lead and steel shields have been designed
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such that direct background radiation cannot reach the counter
crystal. Such so-called "shadow shielding" was used in the
machines in this study.
VITAMIN B12 ABSORPTION MEASURED BY WHOLE BODY COUNTING
The principles of whole body counting were first applied
to the study of vitamin B12 absorption by Reizenstein et al. (1961).
Since that time, and apart from the reports by the. present author
and his colleagues, studies have been made on this subject by
Bozian et al. (1963), Callender et al. (1966), Tappin et al. (1966),
Meyer et al. (1968), Naversten et al. (1969), Boddy et al. (1969),
Irvine et al. (1970), and Cottrall et al. (1971). Heyssel et al.
(1966) have used whole body counting to study the assimilation of
vitamin B12 from natural foodstuffs and to estimate the minimal
daily need for the vitamin in man. Reizenstein et al. (1961) and
Boddy et al. (1969) have reported on double isotope methods whereby
the absorption of free and intrinsic factor bound vitamin B12 can
be studied simultaneously.
There are considerable advantages to studying vitamin B12
absorption by whole body counting. In the first place, it is
possible to measure absorption quantitatively; this can only be
done otherwise by the tedious faecal excretion method or perhaps by
a double isotope hepatic uptake method. In addition, there is no
need to collect urine, stool, or blood samples, the presence of
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renal disease is irrelevant, and no "flushing" doses of nonradio¬
active vitamin B12 are given, thereby avoiding metabolic and
haematologic changes resulting from that procedure. Finally, the
radioactivity left in the body can be measured directly and with a
high degree of sensitivity, so that very small doses of radioactive
material, in the range of 0.1-0.2jac, can be used. As noted by
Glass (1963), however, with modern isotopes this last point is of
little importance.
The main errors inherent in the whole body counting method
have been discussed by Reizenstein et al. (1961), who considered
that there were, three. First, there was the statistical error
inherent in the measurement of radioisotopes, which was 3.0% of the
final count for l.Ouc of 58Co and 3.2% of the final count for 1.One
/ /
of 60Co under the conditions used by these authors. This error is
generally very small and, as estimated by Naversten et al, (1S69),
amounted to about 2.0% which included the errors of patient posi¬
tioning and counting statistics. A second and greater error, how¬
ever, was that due to the redistribution of the isotope within the
body over the first few hours after giving the test dose and before
any excretion of radioactivity had occurred. This results in
difficulty in deciding on the 100% value. . Reizenstein et al.
(1961) noted a mean error of minus 4.1% of the initial count over
1-8 hours after administration of the oral test, dose to 6 subjects,
(range minus 11.1% to plus 4.9%). Warner and Oliver (1966) gave
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a 100% value error of ±3.0% for 58Co; Tappin et al. (1966) a maximum
value of ±10.0% for 58Co, though this was minimized if the 100% value
was taken at 3 hours; Naversten et al. (1969) a value of ±13.0% for
57Co; and Boddy et al. (1969) errors of ±2.7% for 57Co and ±3.4% for
58Co. All these errors were derived from a variable number of repeated
readings within the first 24 hours after giving the test dose, usually
within the first 6 hours. The third error was that of unabsorbed but
as yet unexcreted radioactivity at the time of the final count, wThich
was usually seven days after the test dose was given (range 5-14 days).
Vitamin B12 excretion in the faeces has not generally been appreciable
more than seven days after ingestion (Halsted et al. 1S56) and in the
study of Reizenstein et al. (1961) amounted to only 1.1% of the ini¬
tial count from the seventh to the twenty-second day, which was not
considered very significant. Naversten et al. (1969) assessed the im¬
portance of this factor in 17 subjects by carding out counts on the
seventh and fourteenth days; they found the decrease in retention of
57Co vftamin B12 during this second week to be 2.0% (±3.0%) or 4.0%
(±5.0%), depending on the energy range used for counting, and con¬
cluded that only a very small amount of radioactive vitamin B12 re¬
mains unexcreted after the seventh day.
Although the errors described above are real ones which must
be taken into account in considering results, they are on the whole
not very serious, especially in clinical situations. Furthermore, as
40
Reizenstein et al. (1961) point out, these areas of error can be de¬
fined by measurement.
Until fairly recently, it was generally considered that 58Co
was the only isotope suitable for use in whole body counting studies.
This opinion derived from the fact that, as noted previously, the
use of either 56Co or 60Co resulted in relatively large body doses
of radiation, while 57Co was considered unsuitable for whole body
counting from a technical point of view on account of the compara¬
tively low energy of its gamma rays. More recently, Boday et al.
(1968, 1969) and Naversten et al. (1969) have reported the success¬
ful use of 57Co in whole body counting studies, including studies
of absorption (Boddy et al. 1969, Naversten et al. 1969). This
successful use of 57Co will be supported by the results described
below.
The results which have been obtained by various authors
are shown in Tables III and IV. As can be seen (Table III), though
no studies on the reproducibility of absorption tests in individual
subjects have been done, the range of vitamin B12 absorption is very
wide, varying from 21% to 98% of the test dose. The separation
between control subjects and those with pernicious anaemia is on
the whole very good, though occasional overlapping results occur,
and Irvine et al. (1970) showed that a good separation between
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achieved. Considerable increase in absorption could be demonstrated
when intrinsic factor was added to the test dose in subjects with
pernicious anaemia, and this was not found in 3 subjects with intes¬
tinal malabsorption (Tappin et al. 1966). Table IV shows the results
of two studies where a double isotope absorption test was used, one
form of isotopic vitamin B12 being free and one being bound to in¬
trinsic factor. In both studies there was a very significant increase
in the absorption of the isotopic vitamin B12 bound to intrinsic fac¬
tor in subjects with pernicious anaemia, the single low value (4.0%)
in the study of Reizenstein et al. (1961) being in a patient who had
become resistant to intrinsic factor following therapy with it. Fur¬
thermore, as shown in the study of Boddy et al. (1969), exchange of
the bound and unbound isotopes did not seem to occur. The diminished
absorption of the intrinsic factor bound isotopic vitamin B12 in con¬
trol subjects found by Reizenstein et al. (1961) has been suggested
as being due to technical factors (Boddy et al. 1969).
Heyssel et al. (1966) have used whole body counting to study
the absorption of food vitamin B12, specifically vitamin B12 de¬
rived from lean meat and liver of sheep, and to compare its ab¬
sorption with that of crystalline vitamin B12 (cyanocobalamin).
They found that food vitamin B12 was absorbed as wTell as crystalline
vitamin B12, and that there was a failure of absorption of food vita¬
min B12 in pernicious anaemia. Furthermore, they suggested that
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testing the absorption from liver pate containing 38jug of radioac¬
tive natural vitamin B12, they found that 6 young normal subjects
absorbed 4. l;ug (range 1.9-6.3jug), that 4 old normal subjects ab¬
sorbed 1.7p.g (range 0.9-2.3^), and that 5 subjects with pernicious
anaemia absorbed 0.68pg (range 0-1.41ug).
Comparison of Whole Body Counting with Other Methods of
Measuring Vitamin B12 Absorption.
There have been reports in which whole body counting has been
compared with other methods of measuring vitamin B12 absorption.
Callender et al. (1966) showed that there was a good relation between
the results obtained by the whole body counting and faecal excretion
methods, provided that instances in which inadequate faecal collec¬
tions had occurred were detected and excluded. These results will
be discussed in relation to those obtained in this study, Tappin et
al. (1966) compared the results of whole body counting and urinary
excretion tests carried out simultaneously. They found a reasonable
correlation between the results obtained. The results of urinary ex¬
cretion tests gave a continuous spread of values over a wide range
from 1% to 33%, whereas whole body counting values indicated two
groupings: a group containing the controls, who absorbed more than
35% of the test dose, and an abnormal group who absorbed less than
22%. Cottrall ex al. (1971) confirmed these results and showed that
there was also a reasonable correlation between the whole body count¬
ing and urinary excretion results and the 8 hour plasma radioactivity
A3
level. Cottrall et al. (1971) also commented on the poor reproduci¬
bility obtained between successive absorption tests.
SUMMARY
There are two types of whole body counters, and of these the
solid crystal type is the more versatile and more widely used. A
solid crystal counter was used in the study described below.
Most solid crystal counters utilise a thallium-activated
sodium iodide crystal as a detector of gamma radiation. Incident
gamma radiation evokes the production of photons of light in the
crystal, which are converted proportionally to electrical impulses
and amplified by a photomultiplier. Electronic gates, known as
spectrometers, are used ro screen out all impulses but those in a
desired energy range. Impulses may be counted on either scalers or
ratemeters.
Detector crystals will detect all gamma radiation, .including
that from cosmic sources and natural surrounding objects; this back¬
ground may interfere with counting procedures. In clinical work the
interference due to background radiation can be reduced sufficiently
'by limited lead and steel shields.
Whole body counting has been used by a few groups of investi¬
gators to measure vitamin B12 absorption. Overall, subjects with
pernicious anaemia can be distinguished from control or achlorhydric
subjects with relatively little overlapping of results. Exogenous
intrinsic factor will restore vitamin B12 absorption to normal in
pernicious anaemia, and double isotope tests have been devised to
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demonstrate this.
There are sources of error in measuring vitamin B12 by whole
body counting. The most important of these involve the determination
of the 100% value and the problem of unabsorbed and unexcreted radio¬
activity.
OBJECTIVES OF THE STUDY
The objectives of this study were as follows: (1) to develop
the whole body counting method of measuring vitamin B12 absorption
quantitatively; (2) to investigate the sources of error of the method,
particularly errors due to variation between machines, to estimation
of the 100% value, and to the stool and urine loss of radioactivity;
(3) to try to detect errors due to failure to excrete unabsorbed
radioactivity; (4) to define the limits of normal absorption and de¬
termine whether previously reported wide ranges are due to variable
absorption between subjects or in individual subjects; (5) to define
the range of absorption in pernicious anaemia; (6) to determine the
effect of food on vitamin B12 absorption; (7) to study the relation
of vitamin B12 absorption to intrinsic factor secretory capacity
where the latter is impaired.
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MATERIALS AND METHODS
THE WHOLE BODY COUNTERS
Three machines were used in this study. The first was built in
the Medical Physics Department of the Royal Infirmary, Edinburgh
(R.I.E. I), and this machine was later modified to make the second
machine (R.I.E. II). The third machine was a mobile whole body counter
belonging to the Scottish Research Reactor Center (S.R.R.C.) which was
used for machine comparison studies in cooperation with Dr. Keith Boddy
of the Scottish Research Reactor Center, East Kilbride, Glasgow.
R.I.E. I.
The Apparatus: The detector used a sodium iodide crystal
12.5cm in diameter and 9cm thick. It incorporated a 12.5cm diameter
photomultiplier tube, so that the assembly was an integral crystal-
photomultiplier unit. Results have been obtained using a scaler which
supplies the external high tension and incorporates a single-channel
pulse-height analyser.
The crystal-photomultiplier unit was suspended from a wheeled
gantry (Fig. Z) spanning the couch on which the subject lay; it was
positioned 45cm above the couch. A 2.5cm thick lead shield weighing
50kg surrounded the crystal (Fig. Z) , and this reduced the background
by about 50%, being more effective at lower energies. The shield,
which was 30cm long, 28cm wide, and 19cm high, had a collimating effect
such that the field of view at couch level was just sufficient to in¬
clude the width of the subject being counted. At a point 20cm on
FIG. X: Machine Ft. I.E. I} showing the crystal-photomultiplier
unitj surrourided by a lead shad.ow shield3 suspervded on
a wheeled gantry above the couch used for counting
subjects
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either side of the mid-line the sensitivity had fallen to 85% of the
maximum. The shield had no collimating effect in a longitudinal di¬
rection. The uniformity of response in this direction largely depended
on the length of the scan; variation over the central 100cm was within
± 5%. This central area would include a subject's trunk, where the
majority of the 58Co activity would be found. Under extreme conditions,
with a source placed in positions corresponding to the subject's head
or feet, the sensitivity dropped to 75% of maximum. Uniformity could
have been increased by increasing the length of the scan, but this
would have been offset by the high background associated with the par¬
ticular geometry used.
Counting Method: The dependence of the count rate on the posi¬
tion of radioactivity in the body was reduced by making the crystal scan
over the subject. This was done by moving the detector over the length
of the couch at a steady speed of 1cm per second. In addition, total
counts were made with the subject both prone and supine to correct for
redistribution of radioactivity in an anterior-posterior direction.
One hundred and eighty centimeter scans were done in each direction in
both the prone and the supine position, the total number of counts be¬
ing accumulated by the scaler. The total counting time was 12 minutes.
Energy Range for Counting: The optimum energy range for count¬
ing was determined by making measurements over a small 58Co source
which was placed in various positions inside a water tank 20cm deep;
this was to mimic the redistribution of radioactivity inside a human.
Measurements were made in various energy ranges (Table Y) , the 0.40-0.65
table Yi Relative Counting Rates from a small 58Co source
shewing the effect of attenuation and inverse
square effects in different energy ranges
Channel I II III II+III I+II+III
Energy Mev 0.2-0.4 0.4-0.65 0.65-1.00 0.4-1.00 0.2-1.00
Depth 0 cm 75% 100 100 100 93
5 96 99 94 96 100
10 100 96 77 86 92
15 96 99 94 96 100
20 75 100 100 100 93
s2/b X io~3 1.6 1.8 2.6 4.2 5.3
2 2
S /B = Signal /Background
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Mev range including the 0.51 Mev annihilation peak, and the 0.65-1.00
Mev range including the 0.81 Mev gamma-ray peak. Table 1 shows the
variation in the relative count rate as the depth of the radioactivity
source was increased, the counts from both sides being added together.
2 2
Table H also shows the Signal /Background (S /B) value. Although the
0.40-0.65 Mev range gave the smallest variation in response, counting
over a wide range (0.20-1.00) was only slightly more variable and gave
twice the sensitivity. The advantages of working over this wide range
would be increased by conditions in which the background is lower, as
when a more effective shield is used.
The effect of diluting a small source of 58Co was also studied
(Fig. 3). Curve 0-0 shows the effect of placing a l.O^ic source at the
center of increasing volumes of water. The reduction of the count rate
due. to the dilution effect (curve X-X) was considered to be acceptably
small.
In summary, when absorption tests were carried out, final re¬
sults were calculated for the full 0.20-1.00 Mev range, calculations
always being done in the 0.20-0.66 Mev and 0.66-1.00 Mev ranges as a
checking method.
Sensitivity: This was not of prime importance, as the counter
was designed for clinical application. However, the sensitivity, de¬
fined as the radioactivity which will give a count above the background
equal to three times the standard deviation of the total background
count in 20 minutes, is 0.014jjc—i.e. 1.4% of the dose of l.Ouc (see
below) used in clinical tests.
FIG. 3: Relative counting rate from a 10ml








0 0 Placed at the centre of increasing
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This machine was a modification of R.I.E. I described above. An
additional detector crystal, identical to that described above, was
added so that the subject could be counted from above and below simul¬
taneously. The subject could therefore be counted in the supine posi¬
tion only. In this machine the detectors were in a fixed position and
the subject was moved between them on a motorised couch. In addition,
the shielding of the apparatus was increased (Fig. 4). using 10cm of
lead, to give a shadow shield effect similar to that described by
Warner and Oliver (1966) with the addition of side walls which also
contained 10cm of lead. The lead sheets, mounted on steel plates, sur¬
rounded the crystals and covered an area 70cm across and 95c.m along the
couch. This protection was enough to prevent radiation from the sur¬
roundings reaching the crystals. Apart from these modifications, the
procedures were as described for R.I.E. I above.
This machine (R.I.E. II) was used in the machine comparison
stud}* with machine S.R.R.C. described below. In this study 57Co vita¬
min B12 was also used, and this isotope was counted in the 0.03-0.17
Mev energy range.
S.R.R.C.
This whole body counter is the one described in detail by Boddy
(1967). It utilized a single sodium iodide crystal detector, 29.2cm in
diameter and 10.2cm thick, surrounded by a shadow shield of 10.2cm of
lead. The subject was scanned from head to feet in both the prone and
supine positions, passing beneath the detector on a motorised couch.
FIG. 4: Machine R.I.E. II, showing the greatly increased




Measurements were made in the 0.20-1.00 and 0.66-1.00 Mev ranges for
58Co and in the 0.03-0.17 Mev range for 57Co.
PROFILE SCANNING
An attempt was made to assess the completeness of excretion of
unabsorbed radioactivity from the bowel using sequential profile scan¬
ning in conjunction with the whole body counting. Two machines,
R.I.E. I and R.I.E. II, were used in this study, although the majority
of tests were done with R.I.E. II. Both machines gave similar results.
Scans were carried out at a speed of 1cm per second, with the crystal(s)
collimated by a parallel-sided lead collimator; the collimator had a
lip at the edges giving an effective thickness there of 10cm. Initial¬
ly, scans were carried out with collimator slit widths of 2cm and 5cm,
but it was found that the tracing obtained with the 2cm setting was ir¬
regular. Although the 2cm setting gives better resolution, the irregu¬
larity of the tracing probably resulted from the small amount of radio¬
activity used, resulting in a relatively high statistical fluctuation
in the count rate. Thus, after the initial tests, all scans were done
with 5cm collimator settings. Fig. 5" compares the scans obtained in a
subject who had normal vitamin B12 absorption using both 2cm and 5cm
collimator settings. For profile scanning the crystal(s) were brought
closer to the subject. In the single crystal counter the crystal to
couch separation was reduced from 45cm to 38cm, while in the double
crystal apparatus the distance between the crystals was reduced from
84cm to 70cm. In the single crystal counter, separate scans were done
FIG. 5: The effect of collimator settings on
the regularity of the profile scan








Note the relative irregularity v;ith the 2cm setting,
resulting in difficulty in detecting deflections due
to body radioactivity.
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with the patient supine and prone, while in the double crystal counter
the combined output from the detectors was used to give a single scan.
The output from the crystal(s) was counted on a rate-meter, set to 300
counts per second full scale deflection and a time constant of one
second, and printed out on a paper chart recorder.
Absorption tests were done as described below, using 58Co as
the radioactive tracer, with the exception that profile scans and whole
body counts were done on as many days as possible up to the seventh
day. During the whole of this period 24 hour collections of urine and
stool were made. In some subjects, at the completion of the test, a
proportion of the test dose was put into the rectosigmoid region
through a soft rubber catheter; profile scans were then carried out to
try to detect this.
ABSORPTION TEST PROCEDURES
Tests Performed Without Food: Each subject injested l.O^tc of
58Co contained in 0.5fig of cyanocobalamin with 100ml of water after a
12 hour fast. Subjects were recounted on the seventh day and this re¬
corded the retained radioactivity, which was mainly in the liver.
Tests Performed with Food: After a 12 hour fast, the subject
ate a vitamin Bl2-free meal interspersed with sips of the 58Co vitamin
B12 in 100ml of water. The meal consisted of rice, carrots, turnip,
corn oil, and spices, followed by peaches and 50ml of orange juice
containing lOg of sugar. Only one patient disliked the meal, which was
usually eaten within 15 minutes. Euglena gracilis assay showed that
the whole meal contained less than 0.02pg of vitamin B12.
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It should be noted that, to minimize urinary excretion of some
of the absorbed radioactivity, no injections of vitamin B12 were admin¬
istered during any test. Senocot (1.2g) was always given on the third
day, and subjects were questioned regarding bowel movement before the
final count.
measurements were made over 10 minute periods on each occasion that a
whole body count was done. The standard was l.Ojuc of 58Co in 5 liters
of water in a polythene container. Before a test dose was adminis¬
tered, the background was measured with the subject in position by ac¬
cumulating the counts obtained during two scans in the supine position
and two in the prone position for machine R.I.E. I, and two scans in a
supine position for machine R.I.E. II. This allowed correction to be
made for any reduction in background due to the presence of the subject
and also for any radioactivity already present in the subject. After
administration of the test dose, counting was started immediately to
determine the count rate due to the activity, which should be almost
entirely in the stomach. In 29 subjects the variation in count rate
during the first 6 hours'was tested by repeated counting within that
period. In 16 subjects a 58Co label was used for the vitamin B12, and
in 13 subjects a 57Co label. Measurements were repeated after 7 days,
and the new ratio of patient to standard count rate was used to esti¬
mate the amount of radioactivity retained at that time. To obtain the
subject background, the instrument background was corrected using data
obtained on the first day.
Use of the Counter with Subjects: Background and standard
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Reproducibility: This was tested by carrying out two or more
tests of vitamin B12 absorption in successive weeks. Studies of re¬
producibility were done where test doses were given both with and
without food.
MEASUREMENT OF URINARY AND FAECAL RADIOACTIVITY
Measurements of the urinary excretion of radioactivity after
the ingestion of the test dose were made in 14 control subjects.
Twenty-four hour collections of urine were made, these being continued
for two days in 3 of the subjects, and for seven days in 11 of the
subjects. Measurements of the faecal excretion of radioactivity were
made in 48 control subjects and in 8 subjects with pernicious anaemia.
All stool passed after the ingestion of the test dose was collected
for seven days; in 45 instances the collections were divided into
separate 24 hour periods.
Stool radioactivity was measured in a ring of 12 Geiger-Muller
tubes (Type GM 26 Pb) shielded by 4cm of lead shot. Urine activity
was measured by counting 20ml aliquots in a well-type sodium iodide
crystal counter (Tracerlab Gamma-guard). The crystal was 7.5cm in
diameter and 7.5cm thick with a hole 2.5cm in diameter and 5.0cm deep.
GASTRIC FUNCTION TEST
Augmented histamine secretion tests were carried out after the
method of Kay (1953) on all but the control subjects. In each case
the position of the nasogastric tube was checked radiologically, and
every attempt was made to ensure a full collection of gastric juice by
paying particular attention to the subject's position, by the use of
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deep breathing, and by frequent aspiration of the nasogastric tube by
hand.
Gastric Juice Collection: After aspiration of the fasting se¬
cretions, a basal 60 minute collection of juice was made. One of two
gastric stimulants was then given by the subcutaneous route: histamine
acid phosphate 0.04mg/kg of body weight or pentagastrin b.OO^g/kg of
body xvfeight. When histamine was used, mepyramine maleate (lOOmg) was
given intramuscularly 20-30 minutes beforehand to minimize side-effects.
Gastric juice collections were made over 10 minute periods for one
hour after gastric stimulation. Acid and intrinsic factor production
was measured over this one hour period. During the hour after stimu¬
lation, samples were collected onto ice so that intrinsic factor as
well as acid secretion could be measured. Mucus was removed from all
samples by centrifugation at .2,000rpm for 20 minutes, the pH was
raised at once to 10 with 0.1N sodium hydroxide for 30 minutes to de¬
stroy pepsin (see below) and then returned to pH 7.0 with 0.1N hydro¬
chloric acid before storage at -20°C. Acid content was measured during
titration with 0.1N sodium hydroxide to pH 7.0 using a Beckman model
72 pH meter. Subjects whose gastric juice never fell below pH 6.0 were
designated as achlorhydric.
Intrinsic Factor Stability: The extent to which all the proce¬
dures for collecting gastric juice are necessary is not well known, and
experiments were therefore carried out to investigate how critical they
are to obtaining reproducible results. In the destruction of intrinsic
factor in acidic gastric juice, three main factors have been considered
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important—temperature, pH, and peptic activity—and these are the
factors which were investigated. All intrinsic, factor and pepsin
measurements were made on gastric juice collected after histamine or
pentagastrin stimulation.
In the first experiment the intrinsic factor and pepsin con¬
centrations in samples of acidic gastric juice collected from a subject
with a duodenal ulcer and kept at 37°C, room temperature, and 4°C were
investigated over 24 hours. The pH of the gastric juice was 2.1, which
is optimal for pepsin activity. Aliquots from each sample were removed
at once and at intervals for up to 24 hours for estimation of intrinsic
factor and pepsin activity. The results are shown in Figs. 6-t. Each
value plotted represents the mean of two assays showing a variation of
less than 5%. At 37°C the intrinsic factor concentration was reduced
by half in one hour and had disappeared completely within five hours
(Fig. 6). At room temperature (Fig. 7) and at 4°C (Fig. $) intrinsic
factor concentration was unchanged at 24 hours. At all these tempera¬
tures pepsin was stable.
In the second experiment the effect of raising the pH on in¬
hibiting pepsin activity, or on destroying it, was investigated. Acid¬
ic gastric juice samples were collected at room temperature in 9 sub¬
jects. Pepsin was measured at pH 2.0 in these samples, and the mea¬
surements were then repeated after the juice had been stored at pH 7.0,
or at pH 7.0 after an initial period of 30 minutes at pH 10.0. Each
value represents the mean of two assays showing a variation of less
FIG. 6: Survival of intrinsic factor and pepsin


































































































than 10%. Fig. ^ shows that pepsin is not totally destroyed at pH 7.0
but is after 30 minutes at pH 10.0. The effect of raising the pH of
gastric juice to 10.0 on intrinsic factor concentration was tested in
the same way, and the results in Fig. 10 show that there is no loss of
intrinsic factor activity for up to two hours at this pH.
In the third experiment the effect of a low pH on intrinsic
factor at room temperature was tested. Acidic gastric juice was col¬
lected as described above, and pepsin was destroyed by raising the pH
to 10.0 for 30 minutes. Intrinsic factor was measured in the original
sample, after which the pH was reduced to 2.0 and intrinsic factor
measured at intervals for up to 24 hours. Fig. 11 shows that reducing
the pH to 2.0 did not alter intrinsic factor concentration over this
period.
As it is standard practice to store gastric juice samples at
-20°C before intrinsic factor assay, the effect of this on intrinsic
factor activity was investigated. Pepsin was destroyed in gastric
juice samples as described above, after which they xxrere frozen at
-20°C and thawed twice. This did not alter intrinsic factor activity.
From these experiments it was concluded that the method of
collecting gastric juice used gave an optimal preservation of intrin¬
sic factor.
Gastric Stimulants: During the course of this study it became
apparent that pentagastrin was the gastric stimulant of choice for
these tests, as it produced far fewer side-effects than histamine even
FIG. ?: Effect on pepsin levels of raising
the pH of gastric juice to pH 7.0
and pH 10.0
FIG.10: Effect on intrinsic factor survival
of raising pH to 10.0
FIG. 11: Effect on intrinsic factor survival




when mepyramine had been given beforehand. It had been shown by a
number of different workers (Makhlouf et al. 1966, Wormsley et al.
1966, Multicenter Pilot Study 1967, Konturek 1967) that the two stim¬
ulants, histamine and pentagastrin, gave equivalent results for acid
secretion used in the doses stated above. However, this had not been
shown for intrinsic factor secretion, and an investigation was there¬
fore carried out in 15 subjects chosen so as to cover a wide range of
gastric acid and intrinsic factor secretion. Each of these subjects
had had a gastric function test carried out as described above, using
histamine as the stimulant, for diagnostic purposes. In 13 subjects
the histamine (0.04mg/kg of body weight) had been given subcutaneously
and in 2 by continuous intravenous infusion (0.04rag/kg of body weight/
hour) after the method of Lawrie et al. (1964). Each subject was then
asked to volunteer for a further test. This was performed within
three days of the first test, and pentagastrin, 6-Oug/kg of body
weight subcutaneously or 6.0ug/kg of body weight/hour intravenously,
was given. Single subcutaneous injections of pentagastrin were ad¬
justed to approximately 3ml (Wormsley et al. 1966). Acid and intrin¬
sic factor were measured'as described.
The subjects studied included 4 with pernicious anaemia, 3
with duodenal ulcer, 2 with achlorhydria (one of whom had idiopathic
iron-deficiency anaemia), 2 with pyloroplasty and vagotomy, in one of
whom the vagotomy was shown by an insulin test (Ross and Kay 1964) to
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be incomplete, and one each with gastric ulcer, gastric carcinoma,
pancreatic carcinoma, and iron deficiency anaemia secondary to blood
loss.
Table HI shows the acid and intrinsic factor outputs in the
post-histamine and post-pentagastrin hours in the 13 subjects where
the stimulant had been given subcutaneously. The range of acid secre¬
tion covered was 0-49mEq. There was a good correlation between the
acid, intrinsic factor, and gastric juice volumes produced in response
to the two stimulants; the relevant correlation coefficients and prob¬
ability values are shown in Table 311. The only gross difference was
between the acid productions in subject 11 (TableU); in this case
marked contamination of the gastric juice with bile was seen in the
test where pentagastrin was used.
Figs. 11 and 13 show the paired infusion tests carried out on
two subjects, one with duodenal ulcer (subject 14) and one with pyloro¬
plasty and incomplete vagotomy (subject 15). In both these subjects,
"steady state" acid and intrinsic factor outputs in the second hour of
stimulation were similar. During the first hour of stimulation both
intrinsic factor and acid secretion rose sooner after pentagastrin
than it did after histamine. In subject 15 the peak response to in¬
trinsic factor was lower after pentagastrin, but this subject had
already secreted over 8000ng units in the 40 minutes before pentagas¬
trin was given.
Only one subject (subject 4) complained of nausea after re-






















































































































































TABLE EI I: The correlations between gastric juice volumes, acid
secretions, and intrinsic factor secretions in one
hour after stimulation with histamine and pentagastrin
on separate occasions in thirteen subjects, as well as
the correlations between acid secretion and intrinsic






Gastric juice volume 0.94 < 0.001
Acid secretion 0.96 < 0.001
Intrinsic factor secretion 0.99 < 0.001
Acid and intrinsic factor
secretion
0.93 < 0.001
r = correlation coefficient
p = probability of a chance association between the
observations made
FIG. H: Effect of histamine and pentagastrin on
intrinsic factor (a) and acid (b) secretion
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FIG. 13: Effect of histamine and pentagastrin on
intrinsic factor (a) and acid (b) secretion
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ceiving pentagastrin, in contrast to eight subjects who had striking
flushing and/or headache after receiving histamine.
In this part of the study acid responses to pentagastrin were
similar to those obtained after histamine, which accords with the work
of others (Makhlouf et al. 1966, Wormsley et al. 1966, Multicenter
Pilot Study 1967, Konturek 1967). The intrinsic factor outputs were
also comparable. As the side-effects of histamine may be severe de¬
spite antihistamine cover, it was concluded that pentagastrin was the
stimulant of choice for these tests.
INTRINSIC FACTOR MEASUREMENT
The method used for intrinsic factor measurement was that of
Ardeman and Chanarin (1963), xjhich is based on the observation that
the ability of intrinsic factor in gastric juice to bind radioactive
vitamin B12 is abolished by type I antibody to intrinsic factor. This
antibody is found in the serum of many patients with pernicious anae¬
mia. Gastric juice was collected for intrinsic factor estimation as
described above, and all assays were carried out in duplicate at pH 7.0.
The initial mixture of reagents in the assay used in this
study is summarised in Table VIII. Antisera to intrinsic factor capa¬
ble of blocking the uptake of more than 75ng of vitamin B12 per ml
were used, so that an excess of type I intrinsic factor antibody would
be present. This ensured that the sole variable in the system xjas the
amount of intrinsic factor in the gastric juice. These reagents (Table
VIII) x^ere allowed to mix for 10 minutes, after which 1 ml of 57Co
(l.Ouc/ug) vitamin B12 (400ng/ml) was added to each tube. After a
further 20 minutes, 0.5ml of 20% weight per volume of acid washed and
TABLE VIII: Reagent combination for assay of
intrinsic factor in gastric juice
REAGENTS
TEST SAMPLE SERUM CONTROLS STANDARD
1 2 3 4 5
Phosphate buffer
(ml)
1.0 1.0 1.5 1.5 2.5
Test gastric juice
(ml)
0.5 0.5 - - -
Normal serum
(ml)
1.0 - - 1.0 -
Antiserum
(ml)
- 1.0 1.0 - -
Note that all assays are done in duplicate.
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reactivated charcoal \<ras added to the test samples and serum controls
to remove free vitamin B12. Two minutes later the. mixtures were centri-
fuged for 10 minutes at 2000rpm and the radioactivity in the clear
supernatants and the standard measured.
The difference in count rates between the supernatants from
mixtures 1 and 4 (Table VIII) gives a measure of the combined intrinsic
factor and non-intrinsic factor vitamin B12 binders in the gastric juice
under test. The difference in the count rates between the supernatants
from mixtures 2 and 3 gives a measure of the non-intrinsic factor vita¬
min B12 binders in that gastric juice. Hence the difference between
these two measurements indicates the amount of intrinsic factor which
was in the gastric juice—i.e., where S indicates the count rates from
the supernatants of original mixtures (Table VIII), (SI - S4) - (S2 - S3)
is a measure of the intrinsic factor in the test gastric juice.
The actual amount of intrinsic factor is calculated from the
count rate of the standard. All assays were done in duplicate. Only
those with a difference of less than 10% were accepted.
PEPSIN MEASUREMENT
The measurement of pepsin activity in gastric juice was made by
the method of Hunt (1948) as modified by Bitsch (1966), so that results
could be expressed in mg of pepsin.
STATISTICAL ANALYSES
Statistical tests used were as detailed by Bailey (1968) and
by Siegel (1956).
SUBJECTS
The subjects used in this study were classified as follows.
Patients admitted to hospital for diseases other than those of the
60
alimentary tract, and who had no evidence from the clinical history
or physical examination of bowel disease likely to interfere with
small intestinal absorption, were used as control subjects. All of
these subjects had normal haemoglobin, haematocrit and white blood
cell counts. Achlorhydric subjects were diagnosed on the results of
gastric function tests as described above; those with megaloblastic
anaemia and malabsorption of vitamin B12 which could be reversed by
giving exogenous intrinsic factor, as demonstrated by the urinary
excretion test (Schilling wmmin 1953), were defined as having per¬
nicious anaemia. Gastric ulcer was diagnosed radiologically, Crohn's
disease by radiological methods and rectal biopsy, and coeliac syn¬
drome by the demonstration of atrophy of the upper small intestinal
villi for no known reason. Patients who had had gastric operations
were classified in accordance with the type of surgery which had been
done.
Table TY shows the subjects used in the development, of the
whole body counting method for vitamin B12 absorption and in the
clinical studies; the subjects tested with each of the machines used
in this stage of the study (see below) are shown separately; Table X
shows the total number of procedures carried out on these subjects.
Thirty-four subjects were used in the study to compare, the results
obtained using two machines simultaneously. In these subjects the
diagnosis was not important, but subjects with intact stomachs were
chosen in such a way that a range of absorption from very low, repre¬
sented by subjects with pernicious anaemia, to normal would be
covered.
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THE MEASUREMENT OF VITAMIN B12 ABSORPTION BY WHOLE BODY COUNTING
In this part of the work, particular attention was paid to
those aspects of the whole body counting method for measuring vitamin
B12 absorption where inaccuracies could occur. This included the esti¬
mation of the 100% value, the way in which radioactivity was lost from
the body in urine and stool, the detection of unabsorbed radioactivity
in the bowel which had not been excreted, the normal r*ange of absorp¬
tion, the reproducibility of absorption measurements, a comparison of
the results of measuring absorption with two different whole body
counting machines simultaneously, and a comparison of the results of
absorption measurements obtained by the whole body counting and faecal
excretion methods done simultaneously.
The 100% Value.
The variation in the 100% value was measured in 29 subjects, 16
of whom were given 58Co vitamin B12 and 13 of whom were given 57Co
vitamin B12. Four or five whole body counts were done on each subject
in the seven hours following the administration of the test dose. No
difference was found between machines R.I.E. I and R.I.E. II, nor was
there any difference related to whether or not previous gastric surgery
had been done; all the results are therefore presented together.
Table SI shows the results obtained using 58Co vitamin B12.
There was no significant difference between the results obtained with
the three different counting channels, all giving coefficients of

























































































































































































StandarddeviationV riance MeanVariance:0.20-0.66ev=3.8% 0.66-1.00Mev=3.1% 0.20-1.00Mev=3.2%
variation below 4%. The largest individual coefficient of variation
was 15.3%, and the smallest one 0.7%.
Table XII shows the results obtained using 57Co vitamin B12.
The mean coefficient of variation was 6.9%, the largest coefficient
of variation being 12.1%, and the smallest one 0.7%.
Loss of Radioactivity from the Body.
The Faeces: Loss of radioactivity in the faeces during the
seven days of the test was measured in 45 subjects where faecal col¬
lections had been made in separate 24 hour periods. Fig. 14- shows
that the mean daily faecal excretion of radioactivity had fallen to
0.3% of the test dose by the seventh day; one subject excreted 5.3%
of the test dose on the seventh day, but no other subjects excreted
more than 1.5%. Fig, 15 shows that in 69% of patients the maximal
daily excretion of radioactivity had occurred by the end of the third
day, and that it had occurred in 93% by the end of the fifth day.
Profile scanning: An advantage of measuring vitamin B12
absorption by whole body counting is that in addition to giving quan¬
titative results, collection of stool and urine are not needed. Al¬
though the studies described above indicate that, at least where a
laxative is given, faecal excretion of unabsorbed radioactivity is
largely if not wholly complete in a seven day period, failure of ex¬
cretion of unabsorbed radioactivity remains a serious potential source
of error in the investigation. Tests were therefore done to see
whether the technique of profile scanning could be used to detect re-
TABLE XII: Mean Count Ratesj Standard Deviations,









1 3963 124 3.2
2 3910 247 6.3
3 3211 388 12.1
4 3952 291 7.2
5 4050 133 4.0
6 4400 281 7.9
7 5876 455 7.7
8 4475 607 13.6
9 3740 118 3.2
10 5917 206 3.5
11 4444 642 14.5
12 6080 301 5.0
13 5184 200 1.0
Counting range 0.03-0.17 Mev
Mean variance = 6.9%









1 2 3 4 5 6 7
TIME (Days after dose ingestion)
FIG. IS: Days of maximal excretion of radioactivity
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tained uriabsorbed radioactivity. The reason for thinking that pro¬
file scanning might be a useful adjunct to this whole body counting
method was based on the fact that absorbed radioactivity would be
found mainly in the liver where it might be sufficiently separated
from unabsorbed radioactivity in the bowel to allow the latter to be
detected independently.
Twenty-four subjects were studied. Fifteen absorbed more
than 40% of the test dose. The remaining nine patients all absorbed
22% or less and included subjects with pernicious anaemia (6), coeliac
disease (2), and one patient with Crohn's disease. Representative
profile scan patterns from these patients will be illustrated.
Two profile scan patterns were found. The most common occur¬
red in 21 of the subjects and is illustrated in Fig. 16, which shows
the head-to-toe scans starting from the right. After the test dose
was swallowed, a single peak was obtained over the stomach. Within
24-48 hours this had disappeared to be replaced by two peaks, one
over the liver which was called the "liver" peak, and the second, pre¬
sumed to be in the bowel, which was called an "intestinal" peak. By
the sixth day the intestinal peak had disappeared; this disappearance
coincided with the biggest fall in whole body radioactivity and the
greatest excretion of faecal radioactivity as shown in Fig. 16.
Three subjects had scans in which only 1 peak was seen during
the week. Two of these had severe vitamin B12 malabsorption and the
scans of one are shown in Fig. 1^. By the sixth day the peak had
FIG. 16: Profile scanning during a vitamin B12 absorption
test in a normal subject showing the development
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. 17: Profile scanning during a vitamin B12 absorption
test in a subject with malabsorption showing a
"single peak" pattern due to failure to develop
a "liver peak"
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disappeared, after which whole body retention was 3%. This peak
therefore represented an "intestinal" peak occurring alone. Fig.
1$ shows the only subject in whom normal absorption occurred with
a single peak pattern.
Attempts were made to reproduce the "intestinal" peak by
introducing small proportions of the test dose into the rectum after
the 7th day of scanning. Fig. 19 shows the smallest amount (10% of
the test dose) needed to reproduce the peak in the presence of normal
absorption. In malabsorption, where the "liver" peak was low,
smaller amounts could reproduce an "intestinal" peak; this is shown
in Fig. Z0 (5% of the test dose).
Urine: The possibility that absorbed radioactivity might be
lost by urinary excretion during the seven days allowed to elapse
while faecal excretion of unabsorbed radioactivity was occurring was
investigated in 14 control subjects. Twenty-four hour urine col¬
lections were made for 2 days in 3 subjects, all of whom excreted
less than 0.25% of the test dose in this period. In a further 11
subjects, twenty-four hour urine collections were made for seven days.
Seven subjects excreted less than 1% of the test dose in this period,
three subjects excreted from 1% to 3% of the test dose* and one subject
excreted 7.2% of the test dose in the seven day period. This last
subject had a duodenal ulcer, but was otherwise in good health. He
had received no therapy during the test period, and in particular
had had no parenterally administered vitamin B12.
FIG. 1%: Profile scanning during a vitamin B12
absorption test in a normal subject
This was the only occasion on which a "single peak"
pattern occurred with normal absorption due to failure






FIG. 19: Profile scanning during a vitamin B12
absorption test in a normal subject
The "intestinal peak" could be reproduced with a
minimum of 10% of the test dose of 58Co (O.luc)
placed in the rectosigmoid region.
FIG. 20: Profile scanning during a vitamin B12 absorption



















The "intestinal peak" could be reproduced with a minimum
of 5% of the test dose of 58Co (0.05uc) placed in the
rectosigmoid region. Note the very small "liver peak."
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Normal Absorption and Malabsorption.
In defining the ranges of normal absorption and malabsorption,
a comparison was made between the results obtained in control subjects
and those with pernicious anaemia. The comparison with control sub¬
jects was limited to those with pernicious anaemia because this was the
only group of subjects where vitamin B12 absorption would be abnormal
by definition; other individual subjects who either had a malabsorption
syndrome or had had gastric surgery might or might not malabsorb vita¬
min B12. No patient with a total gastrectomy was studied. Subjects
studied in the fasting state are principally considered in this sec¬
tion, as tests of vitamin B12 absorption are in general done under
these conditions.
The mean absorption from 48 tests done on 24 control subjects
was 64% (Standard Deviation ± 19%), with a range from 30% to 98%. The
mean absorption from 62 tests done on 31 subjects with pernicious
anaemia was 11% (Standard Deviation ± 15%), with a range of 0% to 80%.
Five subjects with pernicious anaemia (16%) had at least one absorption
test giving a value of greater than 30%; the paired test values in
these particular subjects are shown in. Table XIII. On only one occasion
(3%) in all the pernicious anaemia subjects were values above 30% ob¬
tained on each of two occasions. The distribution of results in these
24 control and 31 pernicious anaemia subjects is shown in Fig. 21.
It may be noted for completeness that where the test dose was
given with a vitamin Bl2-free meal, the lowest absorption in 11 control
subjects was 47% and this value was exceeded on at least one occasion
TABLE XIII: Results of absorption tests in four subjects
with pernicious anaemia (PA) where at least
one test gave an absorption value above 30%
of the test dose
PA . Absorption (%)
Patient






FIG. 21: Vitamin B12 absorption measured in the fasting state
by whole body counting in 24 control subjects (48 tests)




□ = Pernicious anaemia
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(57%) by one of 11 pernicious anaemia subjects. That single subject
absorbed 34% on another occasion. The distribution of results in these
11 control and 11 pernicious anaemia subjects is shown in Fig. 21.
Reproducibility of Absorption Tests.
The subjects used in this part of the study are shown in Table
XIV. Fig. 23 shows the relation between two absorption tests done in
the fasting state. There was considerable variation in the results
obtained, and this was especially true in the control and achlorhydric
subjects. The least variation was found in the pernicious anaemia and
malabsorption groups.
Fig. 24- shows that where the vitamin B12 was given with a vita¬
min B12-free meal, the overall correlation between the two tests was
better. This improvement was a statistically significant one for con¬
trol (p<0.01) and for achlorhydric (p<0.05) subjects, but not for
subjects with pernicious anaemia or those who had had a partial gas¬
trectomy. An insufficient number of subjects with malabsorption had
been given tests with vitamin B12-free meals for a comparison to be
made for these subjects.
The mean absorption and standard deviation for each subject
group for each absorption test, done either with or without a vitamin
B12-free meal, as well as the correlation coefficients for the paired
tests and the probability estimate of the significance of these, are
shown in Tables XI and XII. The percentage differences between sequen¬
tial paired tests are shown in Table XIII.
FIG. 21: Vitamin B12 absorption measured with a vitamin B12-free
meal by whole body counting in 11 control subjects (22




|H = Control subjects
□ = Pernicious anaemia



















FIG. 23: Correlation between the first and second
absorption tests in fasting subjects
WHOLE BODY COUNT H (_ % ABSORPTION)
^ = Control subject 0 = Achlorhydria
© = Pernicious anaemia □ = Gastric operation
g| = Intestinal malabsorption
FIG. 2^: Correlation between the first and second absorption
tests in subjects who had vitamin B12-free meals
fa = Control subject 0 = Achlorhydria
@ = Pernicious anaemia q = Gastric operation
S3 = Intestinal malabsorption











Controls Achlorhydria Pernicious anaemia Gastrectomy Malabsorption
24 12 31 13 19
68 61 11 37 39
16 18 121 30 26
60 64 12 50 29
21 18 181 30 23
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The mean absorptions of vitamin B12 were greater when the
tests were done with a vitamin Bl2-free meal in all groups. The
increase was greatest in the gastrectomised subjects (Tables XX and
X5II) . As the groups are small, unequal in numbers, and represent
different subjects, the significance of these differences is difficult
to assess.
Comparison of Results Obtained Using Two Machines Simultaneously.
The variation in the counting-rates on the day of administration
(100% value) showed no consistent or systematic trend with either 58Co
vitamin B12 or 57Co vitamin B12. The results were expressed, there¬
fore, for convenience as coefficients of variation. These are shown
in Table XVIII. There was no significant difference (p)>0.1) between
the two monitors.
The absorption values on the seventh day obtained in both moni¬
tors are shown in Fig. 25". The regression equation was y = l,068x
+ 0.819swhere y is the % absorption found in the S.R.R.C. monitor and
x is that in the R.I.E. II monitor. The correlation coefficient of
0.976 was highly significant, while the regression coefficient did not
differ significantly (p>0.1) from the expected value of 1,0 and the
intercept was not significantly different (p>0.05) from the expected
value of zero. Typical subject and background counting-rates are
given in Table XIX.
The results obtained in this part of the study therefore in¬
dicate that conflicting results obtained in different centers are not
likely to be the result of machine variation.
TABLE XVIII: Summary of variations in the counting rate
up to 6 hours after administration of ayx
oral dose of 58Co Vitamin B12 or 57Co








Standard Deviations of 100% Values
S.R.R.C • R.I.E. II
Min. Max. Mean Min. Max. Mean
58Co 0.20-1.00 16 0.7 8.6 4.1 0.6 9.9 3.4
58Co 0.66-1.00 16 1.2 10.3 5.3 0.7 12.9 3.9
5 7Co 0.17-0.30 13 3.6 11.6 7.1 3.0 15.1 7,1
In a further patient who was monitored only twice in each monitor after
receiving 58Co Vitamin B12, the range was 3.2% in the S.R.R.C. monitor
and 8.9% in the R.I.E. II monitor.
FIG. 25": Comparison of vitamin B12 absorption values
obtained using two machines simultaneously
(correlation coefficient = 0.98)
© - 58Co
0 = 57Co
TABLE XIX: Mean background counting rates in the
R.I.E. II and S.R.R.C. monitors and
typical subject counting rates per uc
Energy Range (Mev) 0.66 - 1.00 0.20 - 1.00 0.03 - 0.17
R.I.E. II background, c.p.m. 250 1300 875
S.R.R.C. background, c.p.m. 255 1140 620
R.I.E. II subject c.p.m./uc 1400 5400 4000
S.R.R.C. subject c.p.m./uc 8400 26,000 9600
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Correlation of Vitamin B12 Absorption Measured by Whole Body
Counting and by Calculating from the Faecal Excretion of
Radioactivity.
In 56 subjects, vitamin B12 absorption was measured by whole
body counting and by the faecal excretion method simultaneously. The
results are shown in Fig. 26, and the line of identity for the test
results has been drawn to show the ideal situation for these paired
results.
Each patient was given careful instructions about the impor¬
tance of a complete collection, but no patient has been excluded from
the study on the basis of an unexpected result. In a number of in¬
stances, a much higher retention is shown by faecal measurements com¬
pared with the whole body counter result. On the other hand, of the
ten instances in which a greater retention is show, by whole body
counting than by faecal measurement, in only one case was the differ¬
ence greater than 8%. It would seem that the much larger discrepan¬
cies below the line of identity (Fig. 26) are due to incomplete stool
collections. This is supported by the fact that 8 patients with
proven pernicious anaemia showed the expected low absorption on
whole body counting (all had absorption of less than 10%), but only
3 on faecal collection. From Fig. 26 it would seem that in at least
13 of the 56 subjects (23.2%) an incomplete collection of faeces was
made.
FIG. 26: Correlation between vitamin B12 absorption
measured simultaneously by whole body counting
and by the faecal excretion test
Faecal Excretion Teat (% Absorption)
f v
= Non-pernicious anaemia
© = Pernicious anaemia
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CLINICAL STUDIES USING WHOLE BODY COUNTING
In this part of the work a study was made of the relation
between intrinsic factor secretion and vitamin B12 absorption. As
far more intrinsic factor is secreted under normal circumstances
than is required for vitamin B12 absorption, subjects who were likely
to have a limited intrinsic factor secretory capacity, by virtue of
having pernicious anaemia, being achlorhydric, or having had a gastric
resection, were studied. In this study tests of intrinsic factor
secretion in response to histamine or pentagastrin were done during
the period when vitamin B12 absorption was being measured. The
concentration of intrinsic factor in the gastric juice secreted within
one hour of stimulation was measured, and the total intrinsic factor
secreted during that hour was calculated from the volume of gastric
juice secreted; the gastric juice volumes secreted by subjects with
pernicious anaemia and achlorhydria are shown in Fig. 2~J. In com¬
paring intrinsic factor secretion and vitamin B12 absorption, no
difference was found dependent on whether intrinsic factor concen¬
tration or the total output of intrinsic factor in the hour following
stimulation were used. The results given therefore refer to total
intrinsic factor secreted in the hour after gastric stimulation.
Fig. 2% shows the relation found between vitamin B12 absorp¬
tion tests done in the fasting state and intrinsic factor secretion.
In most cases two tests of absorption were done, and these are both
shown. In general, subjects with greater intrinsic factor secretory
FIG. 27: Gastric juice volumes in the hour
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capacity absorbed more vitamin B12. This can be illustrated by com¬
paring the highest or lowest absorption value for each individual with
2
the intrinsic factor secretion; as illustrated in Table XX, X tests
based on divisions at 35% of vitamin B12 absorption and an intrinsic
factor secretion level of 300ng units per hour show that those with in¬
trinsic factor secretions above 300ng units per hour absorbed more than
35% of the test dose significantly more often. Nevertheless, overlap¬
ping of values occurred, and it was not possible to separate absolutely
subjects with pernicious anaemia from those with achlorhydria.
Fig. 29 shows the relation between vitamin B12 absorption and
intrinsic factor secretion where the vitamin B12 test dose was taken
with food. In this situation the vitamin B12 test dose might be re¬
tained in the stomach longer, allowing more time for its union with
intrinsic factor, and in addition, the food might stimulate greater
intrinsic factor secretion. There are many fewer subjects for analy¬
sis here, but it can be seen that there is still no clear separation
between those with pernicious anaemia and those with achlorhydria.
The data obtained in this part of the study indicated overall
that, at least when the test dose was given in the fasting state,
those who could secrete more intrinsic factor tended to absorb more
vitamin B12. However, there were certain subjects in whom absorption
was variable, or in whom anomalous absorption seemed to have occurred.
These will be described in more detail.













5 19 X2 = 21.0




1 15 X2 = 21.4
30 8 p = <0.001
p = probability of a chance association between
the observations made.




















Variable Vitamin B12 Absorption: In subjects who had had
a partial gastrectomy or who had malabsorptive disease, two ab¬
sorption tests done during successive weeks could give results in
both the normal absorption range and the malabsorption range.
When the tests were done in the fasting state, 4 of 13 subjects
who had a partial gastrectomy gave one result above the lowest
value in a control (30%) and one below. In 3 of these 4 subjects
one absorption value was above 40% and the other below 20%. Five
of 19 subjects with malabsorptive disease gave similarly confli.cti.ng
results, though in this instance, in four of the subjects, one or
both of the results could be considered as borderline, only one
giving a gross disparity (51% and 14%). Fewer results were avail¬
able where the tests had both been done with a vitamin 3312-free meal,
but it was found that one of 7 subjects who had a partial gastrectomy
gave conflicting results.
Table XXI shows two achlorhydric subjects in whom variable
absorption values occurred. One was found to be achlorhydric in¬
cidentally, his general health did not alter during the test period,
and he received no treatment. On two occasions tests in the
fasting state gave"normal values, and on two occasions tests with
food gave values in the malabsorption range. In general, food was
not found to inhibit vitamin B12 absorption in this study.
The second subject suffered from iron deficiency anaemia of
unknown cause, was achlorhydric, and had a low intrinsic factor
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treatment vitamin B12 absorption in the fasting state was low.
After treatment vitamin B12 absorption with food was very much
higher.
It should be noted that absorption values in achlorhydric
subjects were generally normal. When two sequential tests were
done, all but one of the results in 12 subjects tested in the
fasting state were within the normal range. These tests in¬
cluded those of the achlorhydric subjects reported above. When
the tests were done with food, only one of 6 subjects, the
first achlorhydric subject reported above, fell below the normal
range.
Deficient Intrinsic Factor Secretion with Normal Vitamin B12
Absorption: Table XXII shows two subjects whose intrinsic factor
secretory capacity was very low, being well within the range of
most patients with pernicious anaemia, but who absorbed vitamin B12
normally. In both cases the gastric function test was done twice,
and in the second a barium meal did not slow any gastric deformity
likely to have interfered with the collection of gastric juice. Both
were found to be achlorhydric incidentally. Both had normal serum
folate levels. The first subject had a low serum vitamin B12 level
in spite of normal vitamin B12 absorption on three occasions by
whole body counting, and once by the Schilling test. The second
subject had a low/normal serum vitamin B12 level and three normal
vitamin B12 absorption tests by whole body counting where the test
5>
TABLEXXII:VitaminB12Absorptionwi hInt insicFactorDef ciency(2cases) DiagnosisIntrinsic Factor (ng/hr)VitaminB12S tus
Serum Folate (ng/ml)
WholeBodyC unt Absorption %
Schilling Absorption %




















doses had been given with food. In the third absorption test
(53%), the final count was delayed for two weeks, the passage
of stools was checked by history taking, and laxatives were
given to ensure that all unabsorbed radioactivity had been
eliminated.
Pernicious Anaemia with Relatively High Intrinsic Factor
Secretion: Table XXIII shows three achlorhydric subjects, all
of whom had pernicious anaemia with serum parietal cell auto¬
antibodies; each had malabsorption of vitamin B12 as measured by
whole body counting, which could be reversed with exogenous in¬
trinsic factor as measured by the Schilling test. No gross small
intestinal abnormality was found, and all responded to parenteral
cyanocobalamin therapy. Each had an intrinsic factor secretory
capacity sufficient to allow normal vitamin B12 absorption in


























































WHOLE BODY COUNTING IN THE MEASUREMENT OF VITAMIN B12 ABSORPTION
All of the established vitamin B12 absorption tests described
above are satisfactory for routine clinical purposes, provided their
limitations are kept in mind. In the majority of cases, they will
distinguish between those with and without pernicious anaemia and
will demonstrate the effect of oral intrinsic factor in that disease.
However, with the exception of the faecal excretion test and the
whole body counting test, they give only qualitative or at best semi¬
quantitative results and are therefore unsuitable for a close analysis
of problems of vitamin B12. absorption. It has been claimed (Weissberg
and Glass 1966) that the double isotope modification of the hepatic
uptake test gives quantitative results. But this test depends on
certain assumptions regarding the metabolism in the body of orally
and intravenously administered vitamin B12, it requires the introduc¬
tion of correction factors to allow for the varying counting efficien¬
cies of the two different isotopes used, and it may be subject to
errors resulting from natural variations in liver geometry from sub¬
ject to subject, to say nothing of the effects of liver disease. Fi¬
nally, it is unsuitable for repeated studies on the same subject as a
result of the marked variations in baseline radioactivity of the
liver which occur under these circumstances. In short, though it is
an excellent semi-quantitative test, it has not yet been confirmed
that the hepatic uptake test gives good quantitative measurements.
On the other hand, in spite of some reservations discussed by
Glass (1963), most workers regard the faecal excretion test as being
quantitative. Provided that all unabsorbed radioactivity is col¬
lected as it is passed in the faeces, the absorption from the test
dose can be simply, if indirectly, estimated. The problem,of course,
is that the unaesthetic nature of the test results in a frequent
failure to collect all the faeces passed. Ganatra et al. (1965) and
Campbell and Craswell (1970) have introduced double isotope faecal
excretion tests to overcome this problem, at least in part, but in so
doing the original test loses some of its simplicity by the addition
of another variable.
The use of whole body counting goes a long way to meeting the
requirements for a conceptually simple test which will measure vita¬
min B12 absorption directly and quantitatively, and yet be aesthetic¬
ally acceptable to the subject. Machines such as those used in this
study are becoming increasingly available, and they have a high degree
of sensitivity. The sensitivity of the machines R.I.E. I and R.I.E. II
was of the order of 1.4%. In addition, the machine comparison study,
reported above, indicated that where broadly similar machines are used,
variation between these should not materially affect results. The
machine itself is therefore a very minor source of error.
Nevertheless, there are potentially important sources of error.
The first of these involves the determination of the 100% value. As
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discussed above, this can be reduced at the outset by selecting a
suitable geometry for counting. In the case of the vitamin B12
isotopes, the scanning bed geometry used in this study is probably
the best available. Using 58Co as a label, the mean coefficient
of variation of the 100% count was ± 3.2% in the 0.2-1.0 Mev energy
range. This would mean that a vitamin B12 absorption of 30% could
be 29% or 31%; on the other hand, in individual cases higher coeffi¬
cients of variation were found, and where this was 10%,for example,a
final 30% value could lie anywhere between 26% and 35%. The 100%
error would be somewhat greater where 57Co was used, as the mean
coefficient of variation with this isotope was 6.9%. Overall, the
coefficients of variation of the 100% value in this study matched
favourably with figures given by other workers—for 58Co, ± 3%
(Warner and Oliver 1966), ± 1.0% (Tappin et al. 1966), ± 3.4% (Boddy
et al. 1969), and for 57Co, ±2.7% (Boddy et al. 1969), ± 13%
(Naversten et al. 1969)—though it was not found that the variation
fell after about three hours as reported by Tappin et al. (1966).
Furthermore, direct comparison of the 100% values for 57Co and 58Co
between the R.I.E. II machine and that used by Boddy et al. (machine
S.R.R.C.) showed no significant differences in the coefficients of
variation. Overall,therefore, in the majority of cases the error
in the final absorption value due to the 100% value should be quite
low.
One disadvantage of this test is that seven days elapse
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between giving the vitamin B12 test dose and taking the final count
from which the absorption is calculated. During this time some of
the absorbed vitamin B12 could be excreted in the bile, of which
about a quarter to a third could reach the faeces (Grasbeck et al.
1958), and some could be lost in the urine. The first factor was
not assessed in this study. Grasbeck et al. (1958) showed, however,
that when a 0.5jug test dose was given parenterally, after an equili¬
bration period of four days had passed, about 1.1 (± 0.3)% of the
total radioactive vitamin B12 in the body passed into the bile
daily. If it were assumed that only this amount were passing into
the bile daily after an oral dose, then, assuming 50% absorption in
a normal subject, about 2.5-5.0% of the original test dose would
return to the gut over seven days; this would amount to an error of
about 0.8-1.7% if one-third were excreted in the faeces. The loss
of radioactivity into the urine over the one week period of the test
is probably rarely greater than 1-2% of the test dose as judged by
the results of this study. Occasional subjects may, however, lose
up to 5% during this period for no obvious reason. In summary,
granted a number of assumptions for biliary excretion, the combined
negative error from urine and bile losses of unabsorbed radioactive
vitamin B12 is unlikely to exceed 4% of the test dose in any subject,
and is probably less than half of this on most occasions.
The reason for the seven day delay before taking the final
count is,of course,to allow time for the faecal excretion of un¬
absorbed radioactive material. Failure of excretion of such unab-
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sorbed material in effect constitutes the most important potential
error in the method. The problem is to choose a time giving a
reasonable period for the excretion of unabsorbed radioactivity,
while allowing the test to be completed within a reasonable period
of time. The investigations done in this study suggest that by
the end of a week few subjects are excreting much radioactivity in
the stool, the mean excretion on the seventh day being 0.1% of the
test dose. This agrees with the data of other workers. Naversten
et al. (1969) suggested an average decrease in whole body radio¬
activity of 1.4% between the seventh and fourteenth days in their
recommended optimal energy range for counting; Reizenstein et al.
(1961) suggested a mean decrease of 1.1% between the seventh and
twenty-second days; and Reizenstein and Nyberg (1959) reported that
only 0.3-0.5% of the test dose was excreted on the eighth day of the
test. It may be (Irasbeck et al. 1958) that if there was too long
a delay in taking the final count, a negative error from continued
biliary loss could occur. Clearly it would be useful to have some
way of detecting unabsorbed and unexcreted radioactivity simply. The
testing for radioactivity of at least the last stool passed before
the final whole body count would be one possibility. This, however,
reintroduces an unaesthetic aspect to the test for the subject, and
invites precisely those inaccuracies of collection the whole body
counting test seeks to avoid. Alternatively, a largely non-absorbed
and easily visible marker, such as carmine, could be given with, or
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shortly after, the vitamin B12 test dose and counting delayed until
all colour had disappeared from the stool. This was not done in
the study reported here, but it would have to be shown by faecal
excretion experiments that radioactive vitamin B12 and carmine were
excreted in a similar method. Profile scanning at the time of the
final count is a very simple procedure which requires no patient
cooperation, and the results obtained in this study indicate that
it may be a useful way of checking for unabsorbed and unexcreted
radioactivity. While the full validation of the method would re¬
quire further studies, those obtained ixidicate that where an "in¬
testinal" peak can be seen on the scan, excretion of unabsorbed
radioactivity has not been complete. In spite of the total oral
dose of radioactivity being quite small (l.Ouc), even in the pres¬
ence of a substantial "liver peak" indicating normal absorption,
10% of the test dose can be detected in the rectosigmoid part of
the large bowel. Less (5%) could be detected where the "liver
peak"was small, as in malabsorption. A note of caution has to be
introduced, however, where a single peak scan is seen. This cannot
be accepted as unequivocal evidence that all unabsorbed radioactivity
has been excreted, as such a pattern was seen throughout the week of
an absorption test in 1 of 15 control subjects with normal absorption
and 2 of 9 subjects with vitamin B12 malabsorption. If the results
in the sample of 24 subjects studied in this work are generally repre¬
sentative, then 7% of subjects with normal vitamin B12 absorption and
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22% with vitamin B12 malabsorption will show only single peak scans
during the week of the test. In summary,therefore, at the present
stage of its development, profile scanning should only be used to
detect definite failure to eliminate unabsorbed radioactivity.
Summary.
Only the faecal excretion and whole body counting tests of
vitamin B12 absorption can be considered as quantitative. In the
latter, the whole body counter itself has a high degree of sensitivity,
and variation between machines is probably not a serious source of
error. The most important sources of error arise in determining the
100% count, where mean coefficients of variation range from 3% to 13%,
being somewhat higher for 57Co than 58Co, from losses due to urinary
and biliary excretion of absorbed vitamin which are probably not more
than 4% of the test dose, and from failure of excretion of unabsorbed
vitamin which is probably not a serious error in most subjects counted
no earlier than the seventh day. This last error can be minimized
by giving a laxative during the test, and profile scanning at the time
of the final count may help in detecting subjects where unabsorbed
vitamin has not been excreted.
THE RESULTS OF VITAMIN B12 ABSORPTION TESTS PERFORMED BY WHOLE BODY
COUNTING
Control and Achlorhydric Subjects.
The range of vitamin B12 absorption in control subjects is
very wide, being 30-98% (mean value 64% [S.D.±19]) in the work de-
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scribed here. These results are in keeping with the reports of
others (Table III, Introduction), where absorption values range
from 21% to 98% with test doses of 0.5-l.ljug of vitamin B12. The
results of Irvine et al. (1970) are virtually identical to those
reported above; this can readily be accounted for as these workers
utilised the machine R.I.E. II, used in this study, as well as the
method developed and reported on above. In addition to the wide
range of normal absorption, however, the performance of sequential
tests over a two week period showed that considerable variation
between the two absorption tests could occur (Fig. 23). This re¬
sulted in a poor correlation between the test pairs (Table XI),
with a mean difference between the two absorption tests of 21%
(Table XIII). Studies on the reproducibility of vitamin B12 ab¬
sorption using the whole body counting method have not been re¬
ported previously, but studies using the faecal excretion method
have shown absorption differences between sequential tests of up to
19% (Halsted et al. 1956) and 48% (Meyer et al. 1955). Mean varia¬
tion in both these studies was less than in the present one, being
7% (Halsted et al. 1956)■and 9.3% (Meyer et al. 1955).
Vitamin B12. absorption in the fasting state in subjects who
were achlorhydric, but who did not have pernicious anaemia, did not
differ significantly from normal (Table XI). Only one such achlor¬
hydric patient had an absorption below the lowest limit of normal,
and then on one occasion only (Case 2, Table XXI). These results
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agree closely with those of Irvine et al. (1970) and show that
absorption studies with this method will usually differentiate
between achlorhydric subjects with and without pernicious anaemia.
As with the control subjects, the correlation between sequential
tests was not good (Table XI), though the mean difference between
the two tests was less, being 15% (Table XIII).
The reason for these differences in absorption in the same
subject are not known, and are often attributed to poor reproduc¬
ibility of the method being used (Glass 1963, Townsend et al. 1968).
In the faecal excretion test, as some 20-30% of stool collections
may be incomplete (Callender et al. 1966), this would be a good
reason. However, as the evidence discussed above suggests that
marked retention of unabsorbed radioactivity after a week is prob¬
ably unusual, and in this study all patients ware given a laxative
on the third day of the test to encourage elimination, the high
incidence of variability may be due to variable absorption rather
than to methodological factors. This view is supported by the
observation that variation in absorption test results was much less
in subjects with malabsorption or pernicious anaemia (Table XI),
where the capacity for variation is low. If failure of excretion
of unabsorbed vitamin B12 was a major factor in producing the varia¬
tion in results, greater variation in these groups might have been
expected. It may be that variable results in subjects capable of
normal absorption depends in large part on how much intrinsic factor
happens to be present in the stomach when the test dose is given.
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Pernicious Anaemia.
The mean absorption of vitamin R12 in pernicious anaemia
in the present study was 11.0% (S.D. ±15.0%); this mean value
is comparable to those found by others (Tables III and IV, Intro¬
duction) which range from 3.3% (Bozian et al. 1963) to 13.1%(Meyer
et al. 1968). In studies by other authors, little overlap in
absorption values has been found between subjects with pernicious
anaemia and control subjects, though this has occasionally occurred
(Tables III and IV, Introduction).
An analysis of cases in which the absorption test results
overlapped with the control range was done. In one case (Tappin
et al. 1966) the authors suggested that unabsorbed radioactive
vitamin B12 was still in the bowel; this seemed a good explanation,
as a urinary excretion test done simultaneously gave a value of
only 3.0% (author's lowest limit of normal 7.0%). In the report
of Irvine et al. (1970) 8 of 46 subjects (17.0%) with pernicious
anaemia, 6 of 73 (8.0%) with achlorhydri.a, and 2 of 73 (3.0%) con¬
trol subjects had absorption values between 21.0% and 25.0%, which
seemed to constitute an equivocal range between normal absorption
and malabsorption. Meyer et al. (1968) did not give a range of
normal absorption, but 2 of their 8 cases listed as having perni¬
cious anaemia gave results well above the other six (28.5%, 32.9%);
unfortunately, the definition of pernicious anaemia given by these
authors is very unclear, and as neither of these patients showed
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significant augmented absorption when the test was repeated with in¬
trinsic factor (27.5%, 39.0%), they may not have had pernicious
anaemia at all. Thus, the only instances in which an unaccounted for
overlap between pernicious anaemia, defined by clear diagnostic cri¬
teria, and control or achlorhydric subjects has occurred have been
those of Irvine et al. (1970). These overlapping results were within
a very small range.
In the present series, in which the lowest, absorption of
vitamin B12 by a control was 30.0%, 5 subjects designated as having
pernicious anaemia exceeded this value in at least one of two tests
(Table XIII), and in two further cases a value of 30.0% was
recorded in one of two tests. Only one of these 7 subjects absorbed
30.0% or more of the test dose on both test occasions; in the other
6 subjects, the lower of the two absorption values ranged from 10.0%
to 27.0%. One subject absorbed 39.0% and 80.0% on the two tests.
The first possibility to explain these anomalous results
is that unabsorbed radioactivity had not been excreted. This
would imply failure of excretion in 13.0% of the 62 tests carried
out, in spite of the use of a laxative, which seems a high failure
rate in view of the results of the radioactivity excretion studies
reported above, which were carried out during actual absorption
tests. In those studies, only one of 45 (2.2%) subjects excreted
more than 1.5% of the test dose on the seventh day of the test.
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In addition, none of the pernicious anaemia subjects with
absorption values of 30.0% or more were recorded as having been
constipated during the test. Unfortunately, none were recounted
after seven days.
Another possibility is that the original diagnosis of
pernicious anaemia was wrong in these cases. All subjects were
designated as having pernicious anaemia because they had a mega¬
loblastic marrow with low serum vitamin B12 levels and vitamin
B12 malabsorption corrected with exogenous intrinsic factor as
assessed by the urinary excretion test. The marrow and serum
vitamin B12 levels are unlikely to be wrong, as all marrow films
were examined by very experienced haematologists and the vitamin
B12 levels were done in a research laboratory in duplicate with
control sera known to have normal or low vitamin B12 levels.
The urinary excretion test of vitamin B12 absorption is,
of course, subject to errors due to incomplete collections, and
the loss of even a small volume during the period of peak vitamin
B12 excretion on the first test, where oral intrinsic factor was
not given, could give a result indicating malabsorption. Failure
to give the "flushing" dose of nonradioactive vitamin B12 would
have the same results. The subsequent test with added oral
intrinsic factor would then give a normal result, suggesting a
diagnosis of pernicious anaemia.
As all these pernicious anaemia subjects had intact
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stomachs, by definition, an alternative cause for vitamin B12
deficiency would have to be found. Prolonged dietary vitamin
B12 deficiency, though rare in Britain, could be one cause;
however, none of the pernicious anaemia subjects in this study
had an obviously deficient diet. Adams and Cartwright (1963),
using the urinary excretion test, have shown that gross varia¬
tions occur in the results of vitamin B12 absorption tests in
intestinal malabsorptive disease, so that both normal and ab¬
normal results may be obtained in the same subject. Possiblys
therefore,some of the subjects studied here had intestinal
disease and by chance gave an abnormal, followed by a normal
result unrelated to the giving of oral intrinsic factor. How¬
ever, although all the subjects with malabsorption studied by
Adams and Cartwright (1963) had megaloblastic anaemia, only one
(Case Ml) had unequivocal vitamin B12 deficiency, and that had
been contributed to by a grossly deficient diet. It seems un¬
likely, then, that malabsorptive disease was a cause of many of
the anomalous results in this work, though in the absence of
intestinal studies, an ileal lesion, such as Crohn's disease,
cannot be excluded.
A final possibility for hypothetical consideration would
be that some of the anomalous patients described above did have
pernicious anaemia and did, at least on a single occasion, absorb
a normal amount of vitamin B12 from a small test dose. It may
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be important that the absorption tests were carried out with
crystalline cyanocobalamin, which is not the food form of
vitamin B12. Heyssel et al. (1966) have shown that natural
dietary vitamin B12 was as available for absorption as crystal¬
line cyanocobalamin, at least in normal young adults. It is
interesting to note, however, that notmal older adults absorbed
less of the natural dietary vitamin B12, and that there was some
overlap in absorption values between this group and patients
with pernicious anaemia. The number of subjects studied by
these workers was small, but the results suggested that the
ability to absorb dietary vitamin B12 may normally diminish with
age; whether this also applies to cyanocobalamin was not inves¬
tigated, but other evidence suggests that it may not (Glass et al.
1956, Chow et al. 1956). Finally, there is some evidence that
deoxyadenosylcobalamin may be absorbed more slowly (Lee and Glass
1961) ana possibly with greater difficulty (Heinrich and Gabbe
1964) than cyanocobalamin, although evidence on the latter point
is conflicting (Lee and Glass 1961, Herbert and Sullivan 1964).
It has been stated (Ardeman and Chanarin 1965), that 500ng
of intrinsic factor are needed to effect normal absorption from a
0.5Jig dose of vitamin B12, and, as discussed below, at least a few
subjects v?ith pernicious anaemia can produce around that amount
during histamine or pentagastrin stimulation. It is conceivable,
therefore, when these evidences are put together, that occasionally
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a subject with pernicious anaemia may accumulate sufficient
intrinsic factor in the stomach overnight to allow a reason¬
able absorption from a small vitamin B12 test dose the follow¬
ing morning. The neutral pH and the low pepsin secretion in
these subjects could allow prolonged survival of any intrinsic
factor secreted.
It has to be admitted, however, that the vast number of
vitamin B12 absorption tests in subjects with pernicious anaemia
reported in the literature would suggest that if the above occurs,
it must be relatively rare. Nonetheless, before effective ther¬
apy for pernicious anaemia became available, it was well recognised
that spontaneous remissions could occur in this disease, and that
such remissions could include a striking rise in the peripheral
red blood cell count (Chanarin 1969). These remissions could
conceivably have been the result of a transient increase in vita¬
min B12 absorption. Heyssel et al. (1966) have suggested that
maximal absolute absorption of natural vitamin B12 in normal young
adults occurs from a single intake of 3.0jug, that such an intake
does not interfere with the absorption of a similar intake 4-6
hours later, and that a normal diet could provide three such in¬
takes daily. A subject with pernicious anaemia would only have
to absorb 10% from the first 3.0^ig intake of the day and 5% from
each of two subsequent intakes to acquire 0.6^ in a day; Heyssel
et al. (1966) estimated that the minimal daily vitamin B12 intake
needed to maintain health in man was 0.6-1.2ug.
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Overall, in subjects considered to have pernicious anaemia,
vitamin B12 absorption tests by whole body counting give results
clearly below the lowest limit of normal in the great majority of
cases. Occasional results within the normal range are unusual and
are probably due to the inadequate excretion of unabsorbed radio¬
active vitamin B12 in most cases. In a few cases the diagnosis of
pernicious anaemia may be wrong, and it is theoretically possible
that a subject with pernicious anaemia might occasionally absorb an
amount within the normal range.
Partial Gastrectomy and Intestinal Malabsorptive Disease.
Adams and Cartwright (1963) reported poor reliability and
reproducibility of the urinary excretion test of vitamin B12 absorp¬
tion after partial gastrectomy and in intestinal malabsorptive dis¬
ease. They found consistently normal or abnormal results in only 2
of 8 partial gastrectomy subjects and in only 1 of 7 subjects with
primary malabsorptive disease. Though the results in the present
study are not as striking as those of Adams and Cartwright (1363),
nonetheless their findings were confirmed in that both normal and
impaired absorption results were most often seen in the same subject
in these two groups. The differences in both studies were most
striking in the partial gastrectomy group.
Adams and Cartwright (1963) carried out many tests (modal
number 6) on each subject. Analysis of their results shows that,
where normal and abnormal results were obtained, the majority of
tests were usually in one category. In only 2 of 12 subjects were
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results equally divided between the normal and abnormal ranges. On
these grounds, the authors suggested that only a series of absorption
tests could indicate whether significant malabsorption was likely to
be present.
The reasons for this variability are unknown. After partial
gastrectomy, diminished intrinsic factor secretion certainly occurs
and is an important cause of vitamin B12 malabsorption (Ardeman and
Chanarin 1966). Adams and Cartwright (1963) have in addition suggested
that intrinsic factor secretion may be irregular and intermittent after
partial gastrectomy. Unduly rapid emptying of the gastric remnant, re¬
sulting in poor binding of vitamin B12 and intrinsic factor and little
time for the vitamin to be released from food, might also be important.
Whatever the explanation, however, this variation in absorption may ex¬
plain in part the inability of Mahmud et al. (1971) to demonstrate
vitamin B12 malabsorption in more than a third of their partial gas¬
trectomy subjects where serum vitamin B12 and even red blood cell vita¬
min B12 levels were low. A further explanation for the findings of
Mahmud et al. (1971) is offered below.
In intestinal malabsorptive disease, variable vitamin B12 ab¬
sorption may be due to a fluctuating severity of an ileal lesion or to
the presence of excess bacteria in the small bowel. In addition, how¬
ever, concomitant folate deficiency may give rise to vitamin B12 mal¬
absorption (Scott et al. 1968). Five of the 7 subjects studied by
Adams and Cartwright (1963) probably had folate deficiency.
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The Effect of Food on Vitamin B12 Absorption.
The results of investigations into the effect of food on the
absorption of vitamin B12 have been reviewed in the introductory sec¬
tion of this work. In summary, Swenseid et al, (1954) originally
showed that absorption of vitamin B12 in normal subjects was improved
when it was given with a meal. Deller et al. (1961) could not confirm
these results in normal subjects but found that food increased absorp¬
tion in persons who had had a partial gastrectomy. Turnbull (1967)
has more recently confirmed the results of Deller et al. (1961).
In the work reported above, the mean absorption of vitamin B12
was higher when it was given with a vitamin B12-frea meal in control
and achlorhydric subjects, but most of all in those who had had a par¬
tial gastrectomy. As already pointed out, tests with and without food
were not done on the same subjects, and particularly as the groups
given tests with food were smaller, it is difficult to know the extent
to which the results can be compared. A further note of caution has to
be introduced regarding the results in subjects with partial gastrec¬
tomy, as absorption tests in this group can give very variable results
(Adams and Cartwright 1963), a finding confirmed in this study. How¬
ever, as all reports so far on subjects with partial gastrectomies have
shown increased vitamin B12 absorption in the presence of food, the ob¬
servation is probably a true one.
This has important, implications for studies on the occurrence
of vitamin B12 malabsorption after partial gastrectomy, where tests
done in the fasting state have indicated a 30-40% incidence (Lous and
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Schwartz 1959, Deller et al. 1962, Weir et al. 1966, Hatmgren et al.
1967). It has been suggested (Chanarin 1969) that these studies in
the fasting state may have overestimated the incidence of vitamin B12
malabsorption under normal conditions and that a reduction of serum
vitamin B12 should not be taken as evidence of deficiency. On the
other hand, absorption of crystalline vitamin B12 given with food is
not the same as absorption of natural vitamin B12 from food, and this
makes the above suggestion suspect. Deller et al. (1962) and Mahmud
et al. (1971) have found that partial gastrectomy subjects with re¬
duced serum vitamin B12 levels often did not have reduced absorption
of the vitamin as, assessed by the urinary excretion or the plasma ra¬
dioactivity test. However, as Mahmud et al. (1971) also showed low
red blood cell vitamin B12 levels in 21 of 22 subjects with low serum
levels, it is hard to resist the conclusion that these subjects were
truly vitamin B12 deficient. It may be that persons who have had par¬
tial gastrectomy cannot easily release vitamin B12 from food, but that
once released, the presence of food increases its absorption.
The reason for the increased absorption of vitamin B12 in the
presence of food is unknown. Swenseid et al. (1954) suggested that
food caused the secretion of intrinsic factor, and this may be so, as
Rune (1966) has shown that food can stimulate a maximal acid, and pre¬
sumably therefore intrinsic factor, secretion. This was done by show¬
ing that gastric acid secretion could be calculated indirectly from
the simultaneous changes occurring in blood base levels, an observa¬
tion that has been confirmed by the present author, as shown in Fig. 50.
FIG. 30: Change in blood base excess during a gastric function test,
showing the correlation between the amount of acid retrieved
by nasogastric aspiration and the amount calculated from the
base excess changes.
15 30 (5 60 75 90 105 120
TIME ( minutes)
H = point at which histamine 0.04mg/kg of body weight
was given parenterally.
93
Rurie found that acid secretion calculated in this way was the same
after histamine and after a meat meal. In this regard, Turnbull (1967)
showed that histamine was as effective as food in increasing vitamin
B12 absorption after partial gastrectomy.
Vitamin Bl2-free meals, however, are meat-free meals, and whe¬
ther such food will stimulate much secretion is unknown. An alterna¬
tive explanation may be that gastric emptying is slower when food is
taken, allowing better mixing of the vitamin B12 and intrinsic factor
and some neutralisation of the gastric contents, which would result in
less peptic destruction of the latter. The findings of Irvine et al.
(1970) indicated that pentagastrin did not increase vitamin B12 absorp¬
tion in control or in achlorhydric subjects, even though it did in¬
crease intrinsic factor production in both groups. It may be that
after partial gastrectomy the effect of food on increasing intrinsic
factor secretion is relatively more important in promoting the vitamin
B12 absorption, while in control and achlorhydric subjects its effects
on retarding gastric emptying is more important.
Both in this study and in that of Deller et al.(1961), food did
not improve vitamin B12 absorption in pernicious anaemia. This would
be expected where intrinsic factor secretory capacity was severely re¬
stricted.
A comment may be made here on two achlorhydric subjects who
showed strikingly different vitamin B12 absorption when tests were
done with and without food (Table XXI). The first subject was in
good health, with a normal serum vitamin B12 level and good intrinsic
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factor secretory capacity. The two absorption tests done in the fast¬
ing state were well within the normal range, and those done in the
presence of food fell just below the normal range. In this case, ab¬
sorption was clearly less in the presence of food for no obvious rea¬
son. No feasible explanation can be given.
The second subject, also achlorhydric, presented with iron-
deficiency anaemia and a marked reduction in intrinsic factor secretory
capacity. While still anaemic and before the start of the treatment,
two vitamin B12 absorption tests in the fasting state were at or below
the lower limit of normal. After correction of the anaemia by iron
therapy, absorption tests in the presence of food were well within the
normal range. Each pair of tests correlated fairly well. The increase
in absorption after treatment was greater than the increase found in
any other achlorhydric subject in this study when tests were done with
food. It is tempting to postulate, therefore, that the iron deficiency
was the cause of a temporary vitamin B12 malabsorption corrected by
treatment with iron. Cox et al. (1959) reported that 13 of 25 patients
with iron deficiency had low serum vitamin B12 levels which corrected
on iron treatment alone, and they suggested that iron deficiency pro¬
duces vitamin B12 malabsorption, possibly by reducing intrinsic factor
secretion. Badenoch et al. (1957) noted an association between malab¬
sorption of vitamin B12 and gastric atrophy in iron-deficient subjects,
while Cook and Valberg (1965) showed that iron-deficient subjects with
normal gastric acid secretion had normal vitamin B12 absorption. Cook
and Valberg (1965) concluded that vitamin B12 deficiency in iron-
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deficient states resulted from the presence of independent gastric
atrophy and not from iron deficiency per se. This view is supported
by the work of Shearman et al. (1966), who found that only the idio¬
pathic form of iron-deficiency anaemia was associated with achlor-
hydria and the presence of parietal cell autoantibodies; furthermore,
iron therapy did not alter the achlorhydric state. In the case dis¬
cussed here, there was no increase in intrinsic factor secretion after
correction of the anaemia (Table XXI). This suggests that some other
temporary cause of vitamin B12 malabsorption, corrected by iron ther¬
apy, may have been present during the iron-deficient state, possibly
in the ileum.
It was found that the reproducibility of sequential tests of
vitamin B12 absorption where the test dose was given with food, as op¬
posed to the fasting state, was significantly better for control sub¬
jects and for achlorhydric subjects who did not have pernicious anae¬
mia. Where test doses are given in the fasting state, it is likely
that the amount of intrinsic factor which happens to be available in
the stomach is very variable; in addition, fluid is known to be able
to pass through the stomach very quickly. The capacity for variability
in the amount of intrinsic factor happening to be present in the gas¬
tric lumen would be greatest in these two groups of subjects, accounting
in part at least for the poor reproducibility of fasting state absorp¬
tion tests. The improvement in reproducibility where food was given
could be due in part to increased intrinsic factor secretion, resulting
in an equalisation of the amount of intrinsic factor available, and in
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part to less rapid passage of vitamin B12 from the stomach, allowing
greater time for the binding of these two substances.
Summary.
Measurement of vitamin B12 absorption by whole body counting
gave identical results in control and achlorhydric subjects. The
range of normal absorption is very wide, not only because of varia¬
tions between subjects, but also because of variations in the same
subject. Only 8 of 62 absorption tests on 31 pernicious anaemia
subjects fell in the normal range, and only one such subject gave a
normal value on two occasions. Most of these normal results were
probably due to failure to excrete unabsorbed radioactivity, though
variable intestinal malabsorption of the vitamin may have been mis¬
diagnosed by chance. The possibility that normal absorption of vita¬
min B12 might occasionally occur is discussed. Overall, the test
discriminates well between normal or achlorhydric subjects and per¬
nicious anaemia subjects.
In subjects who had had partial gastrectomy or who had in¬
testinal malabsorption, test results in both the normal and abnormal
range were often obtained. Diminished and erratic intrinsic factor
secretion and variable gastric emptying may be of most importance in
producing this in partial gastrectomy. A fluctuating intestinal
lesion, possibly with folate deficiency contributing to malabsorption
before treatment, may be important in intestinal disease.
The mean absorption of vitamin B12 was greater in controls,
achlorhydric subjects, and especially in those with a partial gas-
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trectomy when the test dose was given with food. This may be due to
increased intrinsic factor secretion due to the food, decreased peptic
destruction of intrinsic factor due to food buffering, and slower gas¬
tric emptying resulting in better mixing. Food also improves test
reproducibility in control and achlorhydric subjects. Comments are
made on unusual results in two achlorhydric subjects and on malabsorp¬
tion after partial gastrectomy.
COMPARISON OF WHOLE BODY COUNTING WITH OTHER METHODS OF MEASURING
VITAMIN B12 ABSORPTION
There have been relatively few studies in which whole body
counting has been compared with other methods of measuring vitamin B12
absorption. The main studies, in addition to that reported above, are
those of Callender et al. (1966), Tappin et al. (1966), and Cottrall
et al. (1971).
Callender et al. (1966) showed that there was a very good cor¬
relation between the faecal excretion and whole body counting methods,
provided that gross discrepancies, accounted for in retrospect by his¬
tory-talcing as being due to inadequate faecal collections, were ex¬
cluded. Two points were clearly important with respect to these lat¬
ter. First, they amounted to 16 of 54 collections (29.6%) and, second,
their inadequacy would not have been recognised had the whole body
counting method not been done as well. These results agree closely
with those reported in this study, where 13 of 56 collections (23.2%)
were thought to have been inadequate. These two studies, therefore,
emphasise that although the faecal excretion method may be a valid
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quantitative test of vitamin B12 absorption, subject-related failures
are rather common, even under research conditions, and there is no
sure way of detecting these failures when only the faecal excretion
test is done.
The studies of Tappin et al. (1966) and Cottrall et al. (1971)
showed that there was a fairly good correlation between the whole body
counting, the urinary excretion, and the plasma radioactivity methods.
No evidence on these points was sought in this study, as the giving of
a "flushing" dose of nonradioactive vitamin B12 was specifically
avoided. However, as judged by the urinary excretion studies reported
above, the supposition of these workers is probably true that the per¬
centage urinary excretion in the 24 hours after giving the "flushing"
dose, added to the eventual whole body retention, gave a good estimate
of the true vitamin B12 retention without a "flushing" dose.
THE RELATION OF INTRINSIC FACTOR SECRETORY CAPACITY TO VITAMIN B12
ABSORPTION
It is now well established that normally intrinsic factor is
secreted in very great amounts even under basal (i.e. unstimulated)
conditions. According to Ardeman (1965), male control subjects se¬
crete 100-8300ng units/hour (mean 2600ng units) in the basal state,
and from 1400 to 21,500ng units/hour on histamine stimulation. Females
secrete about half this amount, which is wholly the result of producing
a smaller volume of gastric juice. This is far greater than the 400-
500ng units needed to restore optimal absorption from l.Oug of vitamin
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B12 in subjects with pernicious anaemia (Ardeman and Cnanarin 1965).
It was for this reason that the relation of intrinsic factor secretion
to vitamin B12 absorption was studied only in subjects with a limited
secretory capacity.
In making this comparison, it is important to recognise that
the accuracy of both the intrinsic factor measurement and the estimate
of vitamin B12 absorption will be at their least. In the intrinsic
factor assay used in this work, duplicate samples were measured for a
preset count of 4000 counts to determine the relative counting rates.
This represents a counting time of about 350 seconds at low intrinsic
factor concentrations. Since the intrinsic factor determination de¬
pends on the difference between counting rates, the accuracy of the
measurement deteriorates at low intrinsic factor concentrations because
the count rates come closer together. Even when differences between
the duplicate assay samples of no more than 10% were accepted, this
meant that the standard error due to statistics could be 50% for very
low intrinsic factor concentrations. For illustrative purposes the
standard error due to statistics was calculated for three subjects;
this and the effect it would have on the calculated total intrinsic
factor output after gastric stimulation are shown in Table XXIV. None¬
theless, in computing the total intrinsic factor secreted after gastric
stimulation, incomplete gastric juice aspiration was probably as impor¬
tant a source of error as that due to counting. This implies that
moderate differences in intrinsic factor output at low levels are prob¬
ably not significant.















For comparable reasons, the whole body counter is also at its
least accurate where there is a low vitamin B12 absorption. Warner
and Oliver (1966), using a counter similar to that used in this study,
found a standard deviation of 10-15% on the final count. Allowing a
5% error on the 100% count, this means a final absorption of 20% could
really be anywhere from 16% to 24%. It is important to bear these
methodological limitations in mind in this intrinsic factor secretion-
vitamin B12 absorption comparison.
In the present study, whether one considered the largest or
the smallest amount a subject absorbed in a sequence of tests in the
2
fasting state, X analysis showed a significant relation between the
amount of vitamin B12 absorbed and the intrinsic factor secretion in
one hour after gastric stimulation. This observation agrees with that
of Ardeman and Chanarin (1965), in which the urinary excretion test
was used to measure vitamin B12 absorption, and was confirmed by Irvine
et al. (1970) using whole body counting tests.
The data of Ardeman and Chanarin (1965), on the other hand,
suggested a sharp separation between subjects with pernicious anaemia,
who secreted little more than 200ng units of intrinsic factor after
gastric stimulation, and those subjects with other conditions. How¬
ever, few subjects with intrinsic factor secretions of 200-lC00ng units
were studied, and no achlorhydric subjects without pernicious anaemia.
The results of the present study suggest that, despite the significant
general relation between intrinsic factor secretion aBd vitamin B12
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absorption, there was considerable overlapping, due both to subjects
who secreted little intrinsic factor and yet absorbed normally, and
vice versa. Irvine et al. (1970) also found a number of achlorhydric
subjects without pernicious anaemia who gave absorption results in the
normal range and yet had intrinsic factor secretion levels similar to
those with pernicious anaemia. The overlapping of achlorhydric and
pernicious anaemia subjects was not obviated by giving the vitamin B12
test dose with food.
These results indicate that, contrary to the suggestion of
some authors (Irvine et al. 1968), the diagnosis of pernicious anaemia
cannot be made with absolute certainty by measuring intrinsic factor
secretory capacity. There is no doubt that all pernicious anaemia
subjects have grossly diminished intrinsic factor secretory capacity,
as compared with controls. Irvine et ai. (1968) suggested from their
study of 81 subjects with pernicious anaemia that intrinsic factor se¬
cretion of greater than 200ng units in the hour after gastric stimula¬
tion rarely if ever occurred, irrespective of whether or not antibody
to intrinsic factor was present in the serum, and that achlorhydric
subjects without pernicious anaemia rarely secreted less than 200ng
units in the same circumstances. In a later publication, however,
these workers (Irvine et al. 1970) found that 10 of 36 achlorhydric
subjects secreted less than lOOng units of intrinsic factor and yet
absorbed 22-58% of a 0.5^cg dose of vitamin B12; 5 of these 10 subjects
secreted hardly any intrinsic, factor, and yet all absorbed more than
fS.
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35% of the test dose by whole body counting. Ardeman and Chanarin
(1965) suggested that subjects with pernicious anaemia secreted less
than 200ng units of intrinsic factor in the hour after gastric stimu¬
lation; but later these workers also found one patient with a normal
vitamin B12 absorption test who secreted only 200ng units, and another
with a similar secretory capacity whose absorption of vitamin B12 was
in the low normal range (Ardeman et al. 1966). The findings, in one of
these two subjects, however, suggested that intrinsic factor secretion
probably varied considerably.
Subjects such as these were found in the present study. In
the two subjects reported in Table XXII, intrinsic factor secretion
was very low on two occasions during the weeks when vitamin 312 ab¬
sorption tests were normal. Nonetheless, occasional vitamin B12 mal¬
absorption, or malabsorption of food vitamin, was suggested by low or
low-normal serum vitamin B12 levels in both these subjects. These
results support those of Whiteside et al. (1964), who found low serum
vitamin B12 levels in 4 subjects with gastric atrophy and normal vita¬
min B12 absorption; these workers also found normal serum vitamin B12
levels in 7 such subjects who showed malabsorption. Irrespective of
the interpretation of these findings, however, it is clear that
achlorhydric subjects without pernicious anaemia may shew intrinsic
factor secretory capacities within the pernicious anaemia range and
yet absorb crystalline vitamin B12 normally.
It is equally interesting and important that subjects with
pernicious anaemia may secrete amounts of intrinsic factor in response
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to gastric stimulation well within the range of achlorhydric subjects
able to absorb vitamin B12 normally. Three such subjects are reported
in Table XXIII, where intrinsic factor secretion ranged from 548 to 825
units/hour after gastric stimulation. All fulfilled the criteria for
pernicious anaemia, and none had gross small intestinal disease. Six
similar subjects have been reported by Wangel et al. (1568) in whom
malabsorption of vitamin B12, reversible with exogenous intrinsic
factor, was well documented; these subjects secreted 420-840ng of in¬
trinsic factor after gastric stimulation. There may be many reasons
for the occurrence of vitamin B12 malabsorption in subjects such as
these, where intrinsic factor secretion, albeit greatly depressed,
seems adequate; such factors would include fluctuating intrinsic fac¬
tor secretion (Ardeman et al. 1966), varying amounts of intrinsic
factor antibodies present in the bowel (Rose and Chanarin 1969), or
the presence of excess numbers of small intestinal bacteria (Sherwood
et al. 1964), Unfortunately, apart from deficient intrinsic factor
secretion, no evidence as to other positive causes of the vitamin B12
malabsorption were found in the subjects reported in Table XXIII.
It is important that collecting the small and often viscid
amounts of gastric juice generally secreted by achlorhydric subjects
may be difficult (Irvine et al. 1970) and failure often results in
marked errors due to incomplete collection. Callencer et al. (1960)
found that the mean volume secreted in pernicious anaemia after hista¬
mine was 11.4ml/45 minutes (i.e. 15.2ml/hour) with a range of 0.5-28.8
ml (i.e. 0.8-38.4ml/hour), and Ardeman (1966) 16ml,/hour (range 2-52ml).
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Neither group found that histamine increased secretion. R^dbro et al.
(1965) found a mean secretion of 24ml in pernicious anaemia. The vol¬
umes obtained after gastric stimulation in this study are shown in
Fig. 27. The mean volume was greater than in the series quoted, being
42ml; this, however, was less than in subjects with achlorhydria, who
secreted a mean of 51ml. The large volumes of juice collected after
gastric stimulation in pernicious anaemia subjects in this study may




In conclusion, it seems that at low intrinsic factor secretory
capacities (<TlOOOng units in one hour after gastric stimulation)
there is a significant relation between the intrinsic factor secretory
capacity and vitamin B12 absorption. The present study shewed that
this relation remained even when the results of more than a single
test in each subject were considered. However, both in this study and
in the work of others, individual subjects may secrete little intrin¬
sic factor and yet absorb vitamin B12 normally, and vice versa. The
problems of ensuring complete gastric juice collections where gastric
secretory capacity is low may account for some of the former cases.
On the other hand, it is likely that once intrinsic factor secretion
has diminished considerably, other factors such as the constancy of
intrinsic factor secretion and the presence of intrinsic factor anti-
105
bodies may determine whether or not malabsorption occurs. Such fac¬
tors may result in malabsorption in pernicious anaemia subjects with
relatively high intrinsic factor secretions.
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